Document:

<PAGE>

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS,
HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                                                  EXHIBIT 10.5

                          DEVELOPMENT SUPPLY AGREEMENT

                                    regarding

                                     IB-367

                                     between

                          Ferring Peptide Production AB
                       P.O. Box 30047, Soldattorpsvagen 5
                                  S-20061 Malmo
                                     Sweden

                                       and

                          Polypeptide Laboratories A/S
                                 Herredsvejen 2
                                  3400 Hillerod
                                     Denmark

                                       and

                       IntraBiotics Pharmaceuticals, Inc.
                                 816 Kifer Road
                                    Sunnyvale
                                California 94086
                                       USA

<PAGE>

         THIS AGREEMENT is entered into on the 3rd day of January, 1997, between
POLYPEPTIDE LABORATORIES A/S, a Danish company incorporated under the laws of
Denmark, with its registered offices at Herredsvejen 2, 3400 Hillerod, Denmark
and FERRING PEPTIDE PRODUCTION AB, a Swedish company incorporated under the laws
of Sweden, with its registered office at Soldattorpsvagen 5, S-20061 Malmo,
Sweden (hereinafter jointly referred to as POLYPEPTIDE), and INTRABIOTICS
PHARMACEUTICALS, INC., a company incorporated in the state of Delaware under the
laws of the United States, with its registered offices at 816 Kifer Road,
Sunnyvale, California 94086, USA (hereinafter referred to as INTRABIOTICS).

                                    RECITALS

         WHEREAS, POLYPEPTIDE has developed or acquired patented and
non-patented inventions, manufacturing and testing practices and procedures, and
know-how, relating to the manufacture and testing of peptides, and owns
production facilities for large scale manufacturing of pharmaceutical peptides;

         WHEREAS, INTRABIOTICS has the priority rights to IB-367 (hereinafter
referred to as "Product"), the specification of which is described in Annex 1
(the "Specification");

         WHEREAS, INTRABIOTICS desires to have POLYPEPTIDE develop a [ * ]
manufacturing process for the Product and to enter into a Supply Agreement with
POLYPEPTIDE for the manufacture and supply of IB-367 for commercial use,

         NOW THEREFORE, the parties hereto agree as follows:

         As used herein, "Affiliate" or a Party shall mean an entity: (i) in
which at least 50 percent of the voting share or other means of control of such
entity are owned or controlled by such Party, or (ii) which owns or controls at
least 50 percent of the voting shares of such Party, or (iii) in which at least
50 percent of such ownership or control is owned or controlled by an entity
owning or controlling at least 50 percent of the voting shares of such Party.

                                  AGREEMENT

1.       DEVELOPMENT PROJECT

         1.1 POLYPEPTIDE will develop a commercial scale solution phase
manufacturing process which will yield Product according to the Specification
contained in Annex 1 (the "Specification"). The Specification of the Product may
be changed from time to time as directed by INTRABIOTICS. Significant changes to
the Specification may result in cost and timing changes to the project. The
parties will negotiate in good faith and make only those necessary changes of
the Time Schedule and/or the Compensation payable to POLYPEPTIDE which are a
direct consequence of the change in the Specification.

         1.2 POLYPEPTIDE will conduct the development project in four phases and
in accordance with the Time Schedule set out in the project plan (Annex 2). Each
phase will have a number of milestones as described in Annex 3.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       1.
<PAGE>

         1.3 PHASE I; will consist of development of the strategy and the
method for [ * ] of the Product, with a [ * ] process ("Process"). In the
course of Phase I, POLYPEPTIDE will produce [ * ] of Product, whereof [ * ]
shall be delivered to INTRABIOTICS and the remaining [ * ] shall be used by
POLYPEPTIDE for [ * ]. Phase I will be completed [ * ] based on signing of
this agreement on or before 3 January 1997.

         1.4 PHASE II; will consist of development and validation of [ * ] of
the Product, preparing of the necessary documentation (including
specifications for raw materials or intermediates, batch records and
in-process controls) and scaling up of the Process. In the course of scaling
up the Process POLYPEPTIDE shall deliver to INTRABIOTICS [ * ] Product for
clinical trials. The [ * ] will be in accordance with [ * ]. The Product for
clinical trials shall be delivered in the amount of [ * ] in [ * ].
Furthermore [ * ] will prepare and maintain Drug Master Files ("DMF") for the
purpose of the IND filing of the Product. [ * ], (as supportive data), will
be conducted by POLYPEPTIDE with Product manufactured in this Phase II.

         1.5 PHASE III; will consist of production and delivery of at least
[ * ]manufactured in [ * ] consecutive conforming batches of at least [ * ]
each utilising the final production process for registration [ * ]. The exact
batch sizes to be mutually agreed upon between the parties but in the absence
of agreement, the batch size shall be [ * ]. [ * ]. POLYPEPTIDE will with
regard to technology and equipment be able to scale up the batch size to at
least [ * ] for later commercial use.

         1.6 PHASE IV; will consist of [ * ] in accordance with the
Specification and the then current ICH guidelines and the compilation of the
DMF for registration purpose.

         1.7 INTRABIOTICS will provide to POLYPEPTIDE existing analytical
methods for testing the Product and a reference sample. POLYPEPTIDE shall use
the analytical methods as outlined in the Specification subject to
modifications to be agreed during the project.

2.       COMPENSATION

         INTRABIOTICS will pay POLYPEPTIDE upon completion of each milestone as
agreed and set out in Annex 3. The total sum for each phase amounts to:

<TABLE>
<S>                        <C>                  <C>
         Phase I           USD                  [ * ]
         Phase II          USD                  [ * ]
         Phase III         USD                  [ * ]     (based on delivery of [ * ] of the Product)
         Phase IV          USD                  [ * ]
</TABLE>

         Payments under this Development Supply Agreement will be made by wire
transfer within [ * ] from the date of completion of the respective milestone
and upon receipt of a corresponding invoice to an account indicated by
POLYPEPTIDE.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       2.
<PAGE>

3.       REPORTS AND VISITS

         During each phase of the development project, POLYPEPTIDE, will make a
monthly status report to INTRABIOTICS by fax with originals by mail (Att.:
Senior Director of Pharmaceutical Development). On a quarterly basis a meeting
will be conducted between the parties to discuss the progress of the development
project. Upon reasonable notice, POLYPEPTIDE will receive visitors from
INTRABIOTICS or another company authorised by INTRABIOTICS to discuss with them
any issue which may arise in connection with the development project.

4.       DELAYS OF THE DEVELOPMENT PROJECT

         4.1 POLYPEPTIDE acknowledges that in light of the time schedule of the
clinical trial and Product registration, timely completion of the development
project is of essential importance to INTRABIOTICS and POLYPEPTIDE shall use its
best efforts to complete the project according to the Time Schedule in Annex 2.

         4.2 If any unforeseen problem arises which may delay the completion of
a phase, POLYPEPTIDE will promptly inform INTRABIOTICS of such problem and
provide its best estimate for the completion of the affected development phase.
If necessary, POLYPEPTIDE will employ [ * ] outside specialists (subject to
confidentiality undertakings pursuant to Section 10) and do its best to overcome
the problem and achieve the timely completion of the development project.

5.       OWNERSHIP OF INTELLECTUAL PROPERTY

         5.1 [ * ] shall own and will have [ * ] and will own [ * ] relating
to the [ * ] or its external advisors in the course of [ * ]. All [ * ] will
be paid by [ * ] will direct all [ * ]. In order to [ * ] will ensure that
the [ * ] is [ * ], and execute such documents, including but not limited to
[ * ], as are necessary for [ * ]. [ * ] will supply to [ * ] copies of [ * ]
on a quarterly basis. Such reports shall also [ * ] is entitled to [ * ].

         5.2 The DMF developed based on the facilities, technology and knowledge
of POLYPEPTIDE is the property of [ * ], which is only permitted to make use of
the DMF [ * ].

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       3.
<PAGE>

6.       PRODUCTION, CGMP AND QUALITY CONTROL

         6.1      GMP PRODUCTION:

         POLYPEPTIDE will manufacture the Product in phases [ * ] of the
development project according to current Good Manufacturing Practice guidelines
("cGMP") as described in the Code of Federal Regulations, Title 21, Part 211 (21
CFR 211) as applicable to Bulk Pharmaceutical Chemicals. Furthermore, [ * ] will
authorise the United States Food and Drug Administration ("FDA") and any other
regulatory agency around the world to review the Drug Master File in support of
the Product registration applications. [ * ] reserves the right to review the
DMF prior to its submission to the FDA. If during the course of this contract
POLYPEPTIDE is inspected by FDA, it will promptly inform INTRABIOTICS that such
inspection has taken place and supply a copy of any FDA Form 483, in the form
that would be available under the Freedom of Information Act, and all other
documentation applicable to the manufacturing of the Product.

         6.2      ACTIVE DRUG SUBSTANCE

                  (a) POLYPEPTIDE will procure, test, and release the necessary
raw material ingredients for the manufacturing of each batch/lot of bulk drug
substance according to the Specification.

                  (b) Certificates of Analysis, copies of Batch Records for
manufacturing, and all Release Documents for items supplied to INTRABIOTICS must
be submitted prior to the receipt of the materials at INTRABIOTICS or its
designee, unless an alternative procedure has been agreed in writing between the
parties.

         6.3      TESTING

                  (a) POLYPEPTIDE is responsible for [ * ]. Testing shall
conform to the Specification and current specifications in the United States
Pharmacopoeia ("USP") or the National Formulary (NF), or the European
Pharmacopoeia if available and/or internal specifications. INTRABIOTICS reserves
the right to review and approve all such specifications prior to their use in
the production of intermediates or bulk drug substance. Such approval shall not
be unreasonably withheld.

                  (b) POLYPEPTIDE and INTRABIOTICS agree that in the event of
unresolved inter-laboratory differences, a mutually agreed upon independent
testing facility shall resolve said discrepancies.

                  (c) All testing laboratories shall have an acceptable retest
and re-sampling procedure on file which is consistent with the Specification and
meets current cGMP laboratory guidelines.

                  (d) The testing laboratory shall be equipped with sufficient
equipment which is maintained in a calibration program adequate to perform
required testing.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       4.
<PAGE>

                  (e) All methods used to evaluate and release drug substance
shall be validated for use or conform to [ * ]. All validation procedures
shall be in accordance with ICH guidelines.

                  (f) POLYPEPTIDE will conduct and furnish the appropriate
inspection, testing and release documents for the following items as part of the
batch record, or minimally reference these documents in the batch record:

                           -        [ * ]
                           -        [ * ]
                           -        [ * ]
                           -        [ * ]
                           -        [ * ]
                           -        [ * ].

         6.4 LABELLING

                  (a) POLYPEPTIDE shall label each container of bulk drug
substance according to the Specification including manufacturer name, name of
product, product code, storage temperature, expiration date (if available),
and quantity and number of containers. Each container will carry a caution
statement as required by the applicable regulations in the country of
shipping, transit and destination. INTRABIOTICS reserves the right to review
and approve the master sample of the bulk drug container labels prior to
their use.

                  (b) Each container will contain a status label such as "IN
QUARANTINE" or "RELEASED" etc.

                  (c) Copies of labels used to label the bulk container will be
kept as part of the batch record.

         6.5 POLYPEPTIDE will maintain reserve samples for each lot of bulk
drug substance sufficient to complete all Certificate of Analysis testing [ * ]
times. Reserve samples shall be stored at the temperature recommended in the
Specification, or if no recommendation, at [ * ]. Samples to be stored by
POLYPEPTIDE for [ * ] unless otherwise agreed between the parties in writing.

         6.6 LOT INFORMATION:

                  (a) POLYPEPTIDE will provide a copy of all information and
records relating to the batch/lot (e.g., expected lot size, yield,
manufacturing deviations or rework).

                  (b) INTRABIOTICS will have the right to review and/or audit
all batch records and test and release data prior to acceptance of the material.

                  (c) Changes to manufacturing parameters or specifications that
may impact the quality or integrity of the Product shall be subject to review
and approval by the INTRABIOTICS QA/QC unit prior to shipment to INTRABIOTICS.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       5.
<PAGE>

         6.7 MASTER BATCH RECORDS:

                  (a) POLYPEPTIDE will prepare Master Batch Records to include
directions in sufficient detail to manufacture the bulk drug substance under
cGMP guidelines. INTRABIOTICS reserves the right to review and approve the
Master Batch Records prior to their use in the production of intermediates or
bulk drug substance.

                  (b) POLYPEPTIDE will notify INTRABIOTICS of proposed
changes to the Master Batch Record in advance of the proposed implementation.
A verbal telephone call outlining significant changes to responsible person
is acceptable, but shall be confirmed in writing; telefax transmission is
acceptable. INTRABIOTICS acceptance or rejection of the proposed changes will
be provided in writing before implementation; telefax transmission is
acceptable.

                  (c) INTRABIOTICS shall be notified about proposed
deviations in a timely manner. INTRABIOTICS will respond to proposed
deviations in writing; telefax transmission is acceptable.

                  (d) Master Batch Record changes shall be finalised in typed
written format and approved in writing by representatives of both POLYPEPTIDE
and INTRABIOTICS.

         6.8 MANUFACTURING:

                  (a) POLYPEPTIDE will provide qualified labour to manufacture
the Product according to approved Master Batch Records, and in full compliance
with the Specification and cGMP rules and regulations. Training records for all
labour utilised shall be made available for INTRABIOTICS' review upon written
requested.

                  (b) Upon request of INTRABIOTICS, POLYPEPTIDE will allow to
have a QA audit of the production operation while in process and a complete
review of all documentation pertaining to the manufacture and test of the
Product. Regular audits of POLYPEPTIDES cGMP compliance status will also be
allowed with adequate advance notice. INTRABIOTICS reserves the right to retain
third party auditors to perform these audits if necessary.

         6.9 STORAGE:

                  (a) POLYPEPTIDE will store the bulk drug Product according to
the Specification, [ * ] for up to [ * ] after release to INTRABIOTICS.

         6.10 SHIPMENT:

                  (a) POLYPEPTIDE will furnish the shipping containers according
to the Specification.

                  (b) POLYPEPTIDE will use its best efforts to deliver the
Product within [ * ] of release.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       6.
<PAGE>

                  (c) POLYPEPTIDE may at the request of INTRABIOTICS prepare one
set of pre-delivery samples to INTRABIOTICS or INTRABIOTICS' designated party.

                  (d) INTRABIOTICS will communicate to POLYPEPTIDE the shipping
address in writing at least 30 days prior to the delivery date.

                  (e) All shipments must be sent to the above address by
overnight courier (24 hours delivery) under [ * ] (Incoterms 1990) delivery
terms unless otherwise agreed.

         6.11 The responsibility of each of the parties concerning Quality
Assurance and Quality Control matters is specified in Annex 4.

         6.12     (a) INTRABIOTICS shall be deemed to have accepted delivery of
Product supplied hereunder unless INTRABIOTICS shall have notified POLYPEPTIDE
of any non-conformity in respect of a shipment within [ * ] following
INTRABIOTICS' receipt of same.

                  (b) Any claim of nonconformity hereunder shall be accompanied
by a report of analysis of the allegedly nonconforming material prepared by or
on behalf of INTRABIOTICS. If POLYPEPTIDE confirms INTRABIOTICS' claim, of
nonconformity, POLYPEPTIDE shall within [ * ] from POLYPEPTIDES confirmation of
nonconformity replace the nonconforming goods with conforming goods to
INTRABIOTICS. Pursuant to written directions from POLYPEPTIDE, INTRABIOTICS
shall either return the nonconforming goods to POLYPEPTIDE, or destroy same,
each [ * ].

                  (c) In case of disagreement between the parties regarding the
conformity or nonconformity of a delivery of the Product, the parties shall
refer the matter for review and/or analysis and final settlement to an
independent expert laboratory to be agreed by both of them. The costs of such
expertise and analysis shall be [ * ].

7.       COMMERCIAL PURCHASE AND SUPPLY

         If INTRABIOTICS decides to use the Process for producing the Product
for commercial sale, INTRABIOTICS agrees to use POLYPEPTIDE as the primary
supplier of the Product under the terms of the Purchase/Supply Agreement entered
into on the date hereof ("Purchase/Supply Agreement").

8.       EFFECTIVE DATE, EXPIRATION AND TERMINATION

         8.1 This Agreement becomes effective on the day of signature.

         8.2 This Agreement will expire [ * ] after [ * ] that the DMF is ready
for submission to FDA for registration purposes provided that POLYPEPTIDE will
complete any ongoing work required for registration. In case INTRABIOTICS after
expiration of this Agreement decides not to continue the registration process of
the Product INTRABIOTICS shall immediately notify POLYPEPTIDE and POLYPEPTIDE
shall have no obligation to continue any such ongoing work for registration.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       7.
<PAGE>

         8.3 In case INTRABIOTICS is in need of further Product after the
completion of this agreement but before the approval by the United States Food
and Drug Administration such Product shall be delivered by POLYPEPTIDE under the
terms of this agreement, [ * ].

         8.4 Each party may terminate this Agreement by written notice if the
other party is breaching materials terms of this Agreement and does not remedy
such breach within [ * ] after receiving written notice specifying the breach
from the non-breaching party.

         8.5 If POLYPEPTIDE has not met the [ * ] or if commercial, clinical, or
toxicological data presented by documentation show that further progress on the
development project cannot be commercially justified by INTRABIOTICS,
INTRABIOTICS may terminate this Agreement by written notice effective [ * ] from
the date of receipt by POLYPEPTIDE. In this event, INTRABIOTICS will pay to
POLYPEPTIDE [ * ] plus all costs [ * ].

         8.6 Clauses 5.1, 5.2, 6.1, 6.5, 7, 8.3, 10 and 11 will survive the
expiration or termination of this agreement.

9.       WARRANTIES

         POLYPEPTIDE warrants that it has the necessary permits, facilities,
knowledge, specialists, and personnel for the manufacture of the Product
(including the scale-up) pursuant to the terms of this Agreement, including that
POLYPEPTIDE is registered with the US FDA as a manufacturer of bulk substances.

         POLYPEPTIDE warrants that all Product supplied to INTRABIOTICS pursuant
to this Agreement shall be manufactured, stored and shipped in accordance with
the applicable Specifications and Master Batch Record and in compliance with all
applicable laws and regulations, including cGMP regulations.

10.      CONFIDENTIALITY

         This Clause shall replace any prior confidentiality agreement entered
into between the parties INTRABIOTICS and POLYPEPTIDE concerning IB-367.

         10.1 Both POLYPEPTIDE and INTRABIOTICS mutually acknowledge and
recognise the valuable and proprietary nature of POLYPEPTIDE Confidential
Information and INTRABIOTICS Confidential Information and agree that the
Confidential Information of the other party shall remain confidential
throughout the term of this Agreement, and until 5 years after its
termination. In this regard, the parties agree to receive and maintain the
Confidential Information of the other party in confidence and to refrain from
any use thereof, in whole or in part, except for the express purposes
authorised by this Agreement.

         10.2 In recognition of the proprietary nature and value of the
Confidential Information and the likelihood of loss of business by the other
party in the event of unauthorised disclosure of its Confidential Information,
the parties agree that the obligations of the Paragraph shall continue unabated
regardless of termination of this Agreement for any reason.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       8.
<PAGE>

         10.3 INTRABIOTICS and POLYPEPTIDE may disclose such Confidential
Information of the other party as is necessary or appropriate in order to have
qualified employees act hereunder. However, no disclosure shall be made without
taking suitable steps to assure that such employee is bound under the
confidentiality requirements at least equal in scope to those of this Agreement.
All reasonable steps shall be taken to assure that the disclosure of the
Confidential Information of the other party to any employee will be limited to
those having a need to know to fulfil the terms and conditions of this
Agreement. Further the receiving party will take all reasonable steps to assure
that its employees will maintain the confidential nature of the other's
Confidential Information. In case external resources are being used, the
provisions for employees also apply for such external resources.

         10.4 Neither party shall be obligated or required to maintain in
confidence any information, even though deemed by the disclosing party to be its
Confidential Information, for which it can be demonstrated by competent
documentary evidence that it was:

                  (a) In the public knowledge prior to the earliest disclosure
made between the parties at any time, whether before, during or after the
effective date of this Agreement; or

                  (b) In the possession of the receiving party without binder of
secrecy prior to the earliest disclosure made between the parties at any time,
whether during or before the effective date of this Agreement; or

                  (c) While originally Confidential Information, subsequently is
received without binder of secrecy from a third party who is free to disclose
the information, as of the date of such third party disclosure; or

                  (d) While originally Confidential Information, and
subsequently becomes part of the public knowledge through no fault of the
receiving party; or

                  (e) Independently developed by the receiving party's employees
or agents provided that those employees or agents had no access to any
corresponding Confidential Information of the disclosing party received
hereunder.

         10.5 The parties may disclose Confidential Information pursuant to an
order of a competent court or administrative agency, provided that the party
subject to such order has informed the other party thereof, and has used
reasonable efforts to limit the scope of the disclosure and to obtain
confidential treatment by the court or administrative agency of Confidential
Information disclosed pursuant to such order.

         10.6 INTRABIOTICS may disclose Confidential Information to potential
and established licensees of the Product, potential and established investors in
INTRABIOTICS, and to other relevant business partners under a separate
confidentiality agreement. However, no disclosure shall be made without taking
suitable steps to assure that such receiving party is bound under the
confidentiality requirements at least equal in scope to those of this Agreement.

         10.7 The parties may disclose Confidential Information to the United
States Food and Drug Administration or such other relevant regulatory agency
world-wide in the course of seeking regulatory approval for the Product.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       9.
<PAGE>

11.      PRODUCT LIABILITY AND INDEMNIFICATIONS

         11.1 INTRABIOTICS shall indemnify, defend and hold POLYPEPTIDE and its
agents, employees and directors (the "POLYPEPTIDE Indemnitees") harmless from
and against any and all liability, damage, loss, cost or expense (including
reasonable attorneys' fees) arising out of third party claims or suits resulting
from the use, sale or promotion of Product or a product containing Product by
INTRABIOTICS, its sublicensees, distributors or agents, except to the extent
that such claims or suits result from negligence or intentional misconduct of
POLYPEPTIDE or a POLYPEPTIDE Indemnitee in the manufacture of the Product. Upon
assertion of such claim or suit, the POLYPEPTIDE Indemnitees shall promptly
notify INTRABIOTICS thereof and INTRABIOTICS shall appoint counsel reasonably
acceptable to the POLYPEPTIDE Indemnitees to represent the POLYPEPTIDE
Indemnitees with respect to any claim or suit for which indemnification is
sought. The POLYPEPTIDE Indemnitees shall not settle any such claim or suit
without the prior written consent of INTRABIOTICS, unless they shall have first
waived their rights to indemnification hereunder.

         11.2 POLYPEPTIDE shall indemnify, defend and hold INTRABIOTICS and its
agents, employees and directors (the "INTRABIOTICS Indemnitees") harmless from
and against any and all liability, damage, loss, cost or expense (including
reasonable attorneys' fees) arising out of third party claims or suits resulting
from negligence or intentional misconduct in the manufacture of Product by
POLYPEPTIDE, except to the extent such claims or suits result from the
negligence or willful misconduct of INTRABIOTICS or an INTRABIOTICS Indemnitee.
Upon assertion of such claim or suit, the INTRABIOTICS Indemnitees shall
promptly notify POLYPEPTIDE thereof and POLYPEPTIDE shall appoint counsel
reasonably acceptable to the INTRABIOTICS Indemnitees to represent the
INTRABIOTICS Indemnitees with respect to any claim or suit for which
indemnification is sought. The INTRABIOTICS Indemnitees shall not settle any
such claim or suit without the prior written consent of POLYPEPTIDE, unless they
shall have first waived their rights to indemnification hereunder.

         11.3 In no event shall either Party be liable to the other for
incidental or consequential damages or for punitive damages as a result of any
breach of this Agreement.

12.      FORCE MAJEURE

         12.1 Neither party is liable for failing to perform or having delayed
the performance of its obligation under this agreement, if the performance is
delayed or precluded by circumstances beyond its control, including but not
limited to fire, flood, war, strike, lock-out, failure or shortage of public
utilities due to governmental decrees, orders or legislation and court
injunctions.

         The party, whose performance is delayed or precluded, shall immediately
inform the other party of the circumstances preventing the performance.

         In the event that the circumstances preventing the performance continue
for more than [ * ], each party will have a right to cancel the Agreement and
neither of the parties will have a right to reimbursement or to any claim for
damages as a result of the cancellation of the Agreement.

13.      ASSIGNMENT

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       10.
<PAGE>

         This Agreement shall be binding upon and inure to the benefit of the
parties hereto and their respective successors and permitted assigns. Neither
party shall assign its rights and obligations under this Agreement without first
obtaining the written consent of the other parties, which consent shall not be
unreasonably withheld. Each of the parties may assign its rights and obligations
to an Affiliate provided that the assigning party shall guarantee its
Affiliate's performance and obligations under this Agreement, or to any
successor by virtue of a merger or acquisition of substantially the entire
business to which this Agreement relates or in the case of INTRABIOTICS to a
licensee of the Product, without the consent, but upon notice to the other
party.

14.      SEVERABILITY

         Should any provision or part of this agreement be held invalid,
illegal, or unenforceable in whole or in part by any court of competent
jurisdiction, this Agreement is deemed modified to the extent necessary to make
it valid and enforceable and the Agreement as thus modified shall be in force to
give effect to the intention of the parties to the extent possible.

15.      APPLICABLE LAW AND JURISDICTION

         All matters arising under or related to the Agreement shall be governed
by and construed under and pursuant to the laws of the State of California
without regard to conflict of laws principles.

16.      ARBITRATION

         All disputes between the parties relating to this Agreement, including
its interpretation that cannot be settled amicably by the parties, shall be
settled by binding arbitration in the state/country of the defending party in
accordance with the Commercial Arbitration Rules of the American Arbitration
Association. The arbitration carried out hereunder shall apply to the exclusion
of regular legal means, provided that the rights of the Parties in urgent
situations in which time is of the essence to obtain proper remedies in court of
law or equity shall remain unimpaired.

17.      PUBLISHING OF THIS AGREEMENT

         Except as otherwise required by law, neither Party shall make any
public disclosure as to the terms or existence of this Agreement without the
prior written consent of the other. Notwithstanding this clause, INTRABIOTICS
may publish that such an agreement has been entered into between the Parties
subject to pre-approval by POLYPEPTIDE of the wording.

18.      COMPLETE AGREEMENT

         The provisions contained in this agreement and its appendices and the
Purchase/Supply Agreement set out the entire agreement between the parties
with respect to the subject matter of this agreement and shall supersede all
previous communication, representations or agreements with respect to the same
subject and may not be amended except by an instrument in writing signed by or
on behalf of the parties.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       11.
<PAGE>

         IN WITNESS WHEREOF, the Parties have caused this Agreement to be
executed by their respective duly authorised officers as of the day and year
first above written, each copy of which shall for all purposes be deemed to be
original.

POLYPEPTIDE LABORATORIES A/S               INTRABIOTICS PHARMACEUTICALS INC.

/s/ Erik Lorentsen                         /s/ Thomas Shepherd
-------------------------------------      -------------------------------------
Erik Lorentsen                             Thomas Shepherd
General Manager                            Vice President Corporate; Development

FERRING PEPTIDE PRODUCTION AB

/s/ Anders J. Andersen
------------------------------------
Anders J. Andersen
General Manager

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       12.
<PAGE>

                                     ANNEX 1

                                  SPECIFICATION

TABLE OF CONTENTS:

PAGES 1 AND 2              INTRABIOTICS QUALITY SPECIFICATION NO.: [ * ]

PAGE 3                     - STORAGE
                           - SHIPMENT

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

<PAGE>

                       INTRABIOTICS QUALITY SPECIFICATION

                                 QA ISSUED COPY
                            SPECIFICATION NO.: [ * ]

<TABLE>

----------------------------------------------------------------------------------------------------------------------
<S>                                      <C>
MATERIAL:                                  FOR INFORMATION ONLY
IB-367-03
----------------------------------------------------------------------------------------------------------------------
DATE EFFECTIVE:                          SUPERCEDES:                            PAGE:
         NOV 26 1996                     [ * ]                                  1 of 2
----------------------------------------------------------------------------------------------------------------------

----------------------------------------------------------------------------------------------------------------------
AUTHOR:                                               DEPT.:                                  DATE:
/s/ Jodi L. Fausnaugh                                 Analytical Development                           11/26/96
----------------------------------------------------------------------------------------------------------------------
APPROVED:                                             DEPT.:                                  DATE:
/s/ William R. Trilsch                                Quality Assurance                                11/26/96
----------------------------------------------------------------------------------------------------------------------
APPROVED:                                             DEPT.:                                  DATE:
/s/ Leo Gu                                            Pharmaceutical Development                       11-26-96
----------------------------------------------------------------------------------------------------------------------

DESCRIPTION:
[ * ]

<CAPTION>
----------------------------------------------------------------------------------------------------------------------
                 TEST                                         SPECIFICATION                              METHOD
----------------------------------------------------------------------------------------------------------------------
<S>                                      <C>                                                       <C>
1.  [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
2.  [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
3.  [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
4.  [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
5.  [ * ]                                [ * ]                                                     [ * ]
---------------------------------------- --------------------------------------------------------- -------------------
</TABLE>

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

<PAGE>

                       INTRABIOTICS QUALITY SPECIFICATION

                                 QA ISSUED COPY
                            SPECIFICATION NO.: [ * ]

<TABLE>

----------------------------------------------------------------------------------------------------------------------
<S>                                      <C>
MATERIAL:                                   FOR INFORMATION ONLY
IB-367-03
----------------------------------------------------------------------------------------------------------------------
DATE EFFECTIVE:                          SUPERCEDES:                            PAGE:
         NOV 26 1996                     [ * ]                                  2 of 2
----------------------------------------------------------------------------------------------------------------------

<CAPTION>
----------------------------------------------------------------------------------------------------------------------
                 TEST                                         SPECIFICATION                              METHOD
----------------------------------------------------------------------------------------------------------------------
<S>                                      <C>                                                       <C>
6.  [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
7.  [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
8.  [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
9.  [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
10. [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
11. [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
12. [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
13. [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
14. [ * ]                                [ * ]                                                     [ * ]
----------------------------------------------------------------------------------------------------------------------
</TABLE>

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

<PAGE>

                                     ANNEX 1

                                  SPECIFICATION

STORAGE:  Store at recommended storage conditions.  [ * ].

SHIPMENT:  [ * ].

NB. The storage container and shipping conditions may be modified in the future
once the proper stability data are available.

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

<PAGE>

                                     ANNEX 2
                                      [ * ]

                                      [ * ]

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

<PAGE>

                                     ANNEX 3

                        MILESTONES AND MILESTONE PAYMENTS

1st  Milestone [ * ]
         Payment of [ * ] will be effected by completion of [ * ] in the Time
         Schedule meaning the completion of the development of [ * ].
         POLYPEPTIDE will at the first milestone supply a small sample of the
         Product (non GMP) together with a written method for the manufacture of
         [ * ] of the Product. [ * ]

2nd Milestone [ * ]
         Is reached after the completion of [ * ], meaning completion of [ * ]
         including the delivery of [ * ] of the Product to INTRABIOTICS. [ * ]

3rd Milestone [ * ]
         After the completion of the [ * ] and the [ * ] for the Product [ * ]

4th Milestone [ * ]
         After the completion of [ * ], meaning completion [ * ] including the
         development of the [ * ] the Product. [ * ]

5th Milestone [ * ]
         After the completion of [ * ] including the supply of [ * ]

6th, 7th, 8th, 9th Milestone [ * ]
         After each [ * ] according to [ * ] and upon receiving [ * ]

10th Milestone [ * ]
         After [ * ] with the written notification from [ * ]

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       2.
<PAGE>

                                                             ANNEX3, PAGE 2 OF 2

                                     ANNEX 3

    MILESTONE AND MILESTONE PAYMENTS

    [ * ]

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

<PAGE>

                                     ANNEX 4

               MATRIX OF RESPONSIBILITY OF THE PARTIES CONCERNING
                      QUALITY ASSURANCE AND QUALITY CONTROL

Product:IB-367

<TABLE>
<CAPTION>
RESPONSIBLE FOR                                            POLYPEPTIDE                INTRABIOTICS
<S>                                                        <C>                        <C>
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]

                                                                     [ * ]                      [ * ]
[ * ]

                                                                     [ * ]                      [ * ]
</TABLE>

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

<PAGE>

<TABLE>
<CAPTION>

ANNEX 4 CONTINUED                                          POLYPEPTIDE                INTRABIOTICS
RESPONSIBLE FOR
<S>                                                                <C>                        <C>
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
     [ * ]                                                           [ * ]                      [ * ]
[ * ]                                                                [ * ]                      [ * ]
     [ * ]                                                           [ * ]                      [ * ]

[ * ].

</TABLE>

Contact person regarding Quality Assurance and Control

POLYPEPTIDE:

[ * ], Director  QA & QC

[ * ].

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

                                       2.

<PAGE>

                    AMENDMENT TO DEVELOPMENT SUPPLY AGREEMENT

This Amendment is made and is effective this first day of July 1997, (the
"Effective Date") by and between Polypeptide Laboratories A/S, a Danish company
incorporated under the laws of Denmark, with its registered offices at
Herredsvejen 2, 3400 Hillerod, Denmark and Ferring Peptide Product AB, a Swedish
company incorporated under the laws of Sweden, with its registered office a
Soldattorpsvaegen 5, S-20062 Malmo, Sweden (hereinafter jointly referred to as
POLYPEPTIDE), and IntraBiotics Pharmaceuticals, Inc., a company incorporated in
the state of Delaware under the laws of the United States, with its registered
office at 816 Kifer Road, Sunnyvale, California 94086, USA (hereinafter referred
to as INTRABIOTICS) and amends the Development Supply Agreement between the
parties dated January 3, 1997 (hereinafter referred to as the Development
Agreement).

WHEREAS, this amendment to the Development Agreement has become necessary as a
result of INTRABIOTICS request for additional supply from POLYPEPTIDE of [ * ]
of IB-367 peptide;

Now therefore, the parties agree to amend the Development Agreement as follows:

AMENDMENT 1.

A new annex 2 and annex 3 have been appended to this Amendment and these annexes
supersede and replace the original annex 2 and annex 3 of the Development
Agreement.

AMENDMENT 2.

Clause 1.4 of the Development Agreement is superseded and replaced by the
following new clause:

1.4      Phase II; will consist of development and validation of [ * ] of the
Product, preparing of the necessary documentation (including specifications of
raw materials or intermediates, batch records and in-process controls) and
scaling up of the Process. In the course of scaling up the Process POLYPEPTIDE
shall deliver to INTRABIOTICS [ * ] Product for non-clinical studies (task 11 of
Annex 2) and [ * ] Product for clinical trials (task 13 of Annex 2). The [ * ]
will be manufactured in accordance with the cGMP guidelines cf. Clause 6.1. The
[ * ] will be delivered in the amount of [ * ] in [ * ] and the [ * ] will be
delivered in the amount of [ * ] in [ * ]. Furthermore, [ * ] will prepare and
maintain Drug Master Files ("DMF") for the purpose of the IND filing of the
Product. [ * ], (as supportive data), will be conducted by POLYPEPTIDE with
Product manufactured in this Phase II.

AMENDMENT 3.

Clause 2 of the Development Agreement, entitled Compensation, is superseded and
replaced by the following new clause:

2.       IntraBiotics will pay POLYPEPTIDE upon completion of each milestone as
agreed and set out in Annex 3. The total sum for each phase amounts to:

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.

                                       1.
<PAGE>

        Phase I          USD  [ * ]
        Phase II         USD  [ * ]
        Phase III        USD  [ * ](based on delivery of 1,500g of the Product)
        Phase IV         USD  [ * ]

Payments under this Development Supply Agreement will be made by wire transfer
within [ * ] from the date of completion of the respective milestone and upon
receipt of a corresponding invoice to an account indicated by POLYPEPTIDE.

END OF AMENDMENTS.

The remainder of the Development Agreement will remain in full force and effect.

As advance consideration for the production of [ * ] of [ * ] Product included
in [ * ] INTRABIOTICS shall pay to POLYPEPTIDE a non-refundable fee of [ * ]
within [ * ] of the effective date of this letter of amendment. This sum is
described in Annex 3 of the Development Agreement as being due in [ * ].

IN WITNESS WHEREOF, the parties have caused this letter of amendment to be
executed by their respective duly authorized officers as of the day and year
first above written, each copy of which shall for all purposes be deemed to be
original.

POLYPEPTIDE LABORATORIES A/S              INTRABIOTICS PHARMACEUTICALS, INC.

/s/ Erik Lorentsen                        /s/ Thomas Shepherd
--------------------------------------    --------------------------------------
Erik Lorentsen                            Thomas Shepherd
General Manager                           Vice President Corporate Development

FERRING PEPTIDE PRODUCTION AB

/s/ Anders J. Andersen
--------------------------------------
Anders J. Andersen
General Manager

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.

                                       2.
<PAGE>

                                     ANNEX 2

                                      [ * ]

                                      [ * ]

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.

                                       1.
<PAGE>

                                     ANNEX 3

                                   (JUNE 1997)

Task numbers refer to the project plan dated 10-06-1997.

1st      Milestone [ * ]
         Payment of [ * ] will be effected by completion of [ * ] in the Time
         Schedule meaning the completion of the development of [ * ].
         POLYPEPTIDE will at the first milestone supply a small sample of the
         produce (non GMP) together with a written method for the manufacture of
         [ * ] of the Product [ * ].

2a       Milestone [ * ]
         Is reached after completion of [ * ], meaning completion of [ * ]
         including the delivery of [ * ] of the Product to IntraBiotics. [ * ].

2b       Milestone [ * ]
         At delivery of [ * ], Product to IntraBiotics, [ * ].

3a       Milestone [ * ]
         After having signed and approved [ * ], for the Product [ * ].

3b       Milestone [ * ].
         After completion of [ * ] part of  [ * ].

4th      Milestone [ * ].
         After the completion of [ * ], meaning the completion [ * ] including
         the development of the [ * ] the Product [ * ].

5th      Milestone [ * ].
         After the completion of [ * ] including the supply of [ * ].

6th, 7th, 8th, 9th Milestone [ * ].
         After each [ * ] according to [ * ] and upon receiving [ * ].

10th     Milestone[ * ].
         After [ * ] with the written notification from [ * ].

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.

                                       1.
<PAGE>

                                                            ANNEX 2, PAGE 2 OF 2

                                     ANNEX 3

         MILESTONE AND MILESTONE PAYMENTS

         [ * ]

[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS
AMENDED.

                                       1.<PAGE>

--------------------------------------------------------------------------------

                              AMENDED AND RESTATED

                               FRANCHISE AGREEMENT

                                     Between

                              THE CITY OF NEW YORK

                                       and

                       METROMEDIA FIBER NETWORK NYC, INC.

                        Franchise for Local High-Capacity
                           Telecommunications Services

                             Dated February 28, 2000

--------------------------------------------------------------------------------

<PAGE>

                                TABLE OF CONTENTS

                                                                            Page
                                                                            ----
SECTION 1 -- DEFINED TERMS ...............................................    2

SECTION 2 -- GRANT OF AUTHORITY ..........................................    7

      2.1   Term .........................................................    7

      2.2   Conditions to Execution ......................................    7

            2.2.1 Certain Actions by the Company Before Execution ........    7

            2.2.2 Vendox .................................................    7

      2.3   Nature of Franchise, Effect of Termination and Renewal .......    7

            2.3.1 Nature of Franchise ....................................    7

            2.3.2 Effect of Termination ..................................    8

            2.3.3 Renewal ................................................    8

      2.4   Conditions and Limitations on Franchise ......................    8

            2.4.1 Not Exclusive ..........................................    8

            2.4.2 Construction of System .................................    9

            2.4.3 Public Works and Improvements ..........................    9

            2.4.4 No Waiver ..............................................   10

            2.4.5 No Release .............................................   10

      2.5   Renegotiation of Agreement ...................................   10

SECTION 3 -- SERVICE .....................................................   11

      3.1   No Interference ..............................................   11

      3.2   No Monopoly ..................................................   11

      3.3   No Discrimination ............................................   11

      3.4   Service ......................................................   11

SECTION 4 -- TARIFF FILINGS ..............................................   1l

                                      -i-
<PAGE>

                                                                            Page
                                                                            ----

      4.1   Tariffs .......................................................   11

SECTION 5 -- CONSTRUCTION AND TECHNICAL REQUIREMENTS ......................   12

      5.1   General Requirement ...........................................   12

      5.2   Quality .......................................................   12

      5.3   Licenses and Permits ..........................................   12

      5.4   Relocation of the System ......................................   12

            5.4.1 New Grades or Lines......................................   12

            5.4.2 City Authority to Move Wires ............................   12

            5.4.3 Company Required to Move Wires ..........................   13

      5.5   Protect Structures ............................................   13

      5.6   No Obstruction ................................................   13

      5.7   Safety Precautions ............................................   13

            5.8.1 General Requirement .....................................   13

            5.8.2 Indemnification .........................................   14

            5.8.3 Other Purposes ..........................................   14

            1.1.4 Withdrawals from the Performance Bond/Security Fund .....   15

            5.8.5 Notice of Withdrawals ...................................   15

            5.8.6 Replenishment ...........................................   15

            5.8.7 Not a Limit on Liability ................................   16

            5.8.8 Form ....................................................   16

SECTION 6--EMPLOYMENT AND PURCHASING ......................................   16

            6.1   Right to Bargain Collectively ...........................   16

            6.2   Local Preference ........................................   16

            6.3   City Vendors ............................................   17

            6.4   Equal Employment Opportunity ............................   17

                                      -ii-
<PAGE>

                                                                            Page
                                                                            ----
            6.5   Local Law 33 ............................................   17

            6.6   Enforcement .............................................   17

SECTION 7 -- COMPENSATION AND OTHER PAYMENTS ..............................   18

            7.1   Compensation ............................................   18

            7.1.1 Compensation ............................................   18

            7.1.2 Timing ..................................................   19

            7.1.3 Records and Audits ......................................   19

            7.1.4 Reservation of Rights ...................................   19

            7.1.5 Ordinary Business Expense ...............................   19

            7.2   Other Payments ..........................................   20

            7.2.1 Franchising Costs .......................................   20

            7.2.2 Future Costs ............................................   20

            7.3   No Credits or Deductions ................................   20

      7.4   Interest on Late Payments .....................................   21

      7.5   Method of Payment .............................................   21

      7.6   Continuing obligation and Holdover ............................   22

SECTION 8 -- OVERSIGHT AND REGULATION .....................................   22

      8.1   Protection From Disclosure ....................................   22

      8.2   Oversight .....................................................   22

      8.3   Notification to City ..........................................   22

      8.4   Regulation by City ............................................   23

      8.5   Reports .......................................................   23

            8.5.1 Status Reports ..........................................   23

            8.5.2 Financial Reports .......................................   23

            8.5.3 Ownership Reports .......................................   24

                                     -iii-
<PAGE>

                                                                            Page
                                                                            ----
            8.5.4 Additional Reports ......................................   24

            8.5.5 Additional Information and Reports ......................   24

            8.6   Additional Filings ......................................   24

            8.7   Books and Records/Audit .................................   24

            8.7.1 Books and Records .......................................   24

            8.7.2 Right of Inspection .....................................   25

      8.8   Compliance With "Investigations Clause" .......................   25

SECTION 9 -- RESTRICTIONS AGAINST ASSIGNMENT AND OTHER TRANSFERS ..........   26

      9.1   Transfer of Interest ..........................................   26

      9.2   Transfer of Control or Stock ..................................   26

      9.3   Petition ......................................................   26

      9.4   Consideration of the Petition .................................   27

      9.5   Conditions ....................................................   27

      9.6   Permitted Encumbrances ........................................   27

      9.7   Consent Not a Waiver ..........................................   28

      9.8   Petitions From Persons Other Than the Company
            Seeking Control Over the Company ..............................   28

SECTION 10 -- LIABILITY AND INSURANCE .....................................   28

      10.1  Liability and Indemnity .......................................   28

            10.1.1 Company ................................................   28

            10.1.2 No Liability For Public Work, etc ......................   29

            10.1.3 No Liability for Damages ...............................   29

            10.1.4 Defense of Claim, etc ..................................   29

      1.2   Insurance .....................................................   30

            10.2.1 Specifications .........................................   30

                                      -iv-
<PAGE>

                                                                            Page
                                                                            ----
            10.2.2 Maintenance ............................................   30

            10.2.3 Adjusted Insurance Coverage ............................   30

            10.2.4 Liability Not Limited ..................................   31

SECTION 11 -- SPECIFIC RIGHTS AND REMEDIES ................................   31

      11.2  Default .......................................................   31

            11.2.1 Events of Default ......................................   31

            11.2.2 Cure Procedures ........................................   32

            11.2.3 Remedies of the City ...................................   32

      11.3  Termination ...................................................   33

            11.3.1 Termination Events .....................................   33

            11.3.2 Rights Upon Termination ................................   34

            11.3.3 Price ..................................................   34

            11.3.4 Company's Obligations ..................................   35

      11.4  Removal .......................................................   36

            11.4.1 Discretion of DoITT ....................................   36

            11.4.2 Failure to Commence Removal ............................   37

            11.4.3 No Condemnation ........................................   37

      11.6  Other Provisions ..............................................   38

SECTION 12 -- SUBSEQUENT ACTION ...........................................   38

      12.1  Compensation ..................................................   38

      12.2  Procedure for Subsequent Invalidity ...........................   39

            12.2.1 Declaration of Invalidity or Injunction ................   39

            1.1.2 Continued Compliance ....................................   39

            12.2.3 Negotiations to Amend Agreement ........................   39

SECTION 13 -- MISCELLANEOUS ...............................................   40

                                      -v-
<PAGE>

                                                                            Page
                                                                            ----
      13.1  Appendices ....................................................   40

      13.2  Action Taken by City ..........................................   40

      13.3  Entire Agreement ..............................................   40

      13.4  Delays and Failures Beyond Control of Company .................   40

      13.5  Notices .......................................................   41

      13.6  General Representations, Warranties and
            Covenants of the Company ......................................   41

            13.6.1 Organization, Standing, Power and Ownership ............   41

            13.6.2 Authorization; Non-Contravention .......................   41

            1.1.3 Consent .................................................   42

            13.6.4 Compliance with Law ....................................   42

            13.6.5 Litigation; Investigations .............................   42

            13.6.6 Fees ...................................................   43

            13.6.7 Criminal Acts ..........................................   43

            13.6.8 Misrepresentation ......................................   43

      13.7  Additional Covenants ..........................................   44

            13.7.1 Compliance with Laws; Licenses and Permit ..............   44

            13.7.2 Criminal Acts ..........................................   44

            13.7.3 Maintain Existence .....................................   45

            13.7.4 Condition of System ....................................   45

      13.8  Binding Effect ................................................   45

      13.9  No Waiver; Cumulative Remedies ................................   45

      13.10 No Opposition .................................................   46

      13.11 Partial Invalidity ............................................   46

      13.12 Headings ......................................................   46

      13.13 No Agency .....................................................   46

                                      -vi-
      <PAGE>

                                                                            Page
                                                                            ----
      13.14 Governing Law .................................................   47

      13.15 Survival of Representations and Warranties ....................   47

      13.16 Delegation of City Rights .....................................   47

      13.17 Claims Under Agreement ........................................   47

      13.18 Modification ..................................................   48

      13.19 Maintain Office ...............................................   48

      13.20 Service of Process ............................................   48

      13.21 Compliance With Certain City Requirements .....................   48

      13.22 Matching Provision ............................................   48

      13.23 Joint Services ................................................   49

                                     -vii-
<PAGE>

                                   APPENDICES

Appendix A .....  Franchise Area

Appendix B .....  Construction Terms, Schedule, and Sequence

Appendix C .....  Initial Backbone

Appendix D .....  Telecommunications Services the franchisee intends (as of
                  the Effective Date) to offer and additional Telecommunications
                  Services authorized to be offered by the franchise

Appendix E .....  Service to he provided to the City, and related obligations

Appendix F .....  Investigations Clause

Appendix G .....  Ownership and Control of franchisee as of the Effective Date
                  and any approved mortgages, pledges and leases

Appendix H .....  MacBride Principles

Appendix I .....  Local Law 33

Appendix J .....  Resolution of the Franchise and Concession Review Committee

                                     -viii-
<PAGE>

      THIS AGREEMENT, dated as of 28th day of February, 2000 (the "Effective
Date"), is by and between THE CITY OF NEW YORK (as defined in Section 1 hereof,
the "City") and METROMEDIA FIBER NETWORK NYC, INC., whose principal place of
business is located 1 North Lexington Avenue, White Plains New York 10601 (as
defined in Section 1 hereof, the "Company"), (each, a "party" and collectively,
the "parties").

                                   WITNESSETH

      WHEREAS the City and National Fiber Network, Inc. ("NFN") previously
entered into a franchise agreement (as amended, the "Original Agreement") dated
as of the 20th day of December, 1993 (the "Original Agreement Date") pursuant to
which NFN was granted a franchise to install cable, wire, fiber optic
telecommunications cable or other transmission medium that may be used in lieu
of cable, wire or fiber optic telecommunications cable for the same purposes and
related equipment and facilities on, over, and under the City's Inalienable
Property to be used in providing Telecommunications Services:

      WHEREAS NFN transferred the Original Agreement to the Company as permitted
by resolution passed by the New York City Franchise and Concession Review
Committee (as defined in Section 1 hereof, the "FCRC") on September 10, 1997
(Cal. No. 3);

      WHEREAS, the City and Company wish to amend and restate the Original
Agreement to reflect certain additional developments and to incorporate the
parties' understanding with respect to the System and the Services, and to
replace the Original Agreement with this Agreement;

      WHEREAS, the New York City Department of Information Technology and
Telecommunication (as defined in Section 1 hereof, "DoITT"), on behalf of the
City, has the authority to grant franchises involving the occupation or use of
the Inalienable Property (as defined in Section 1 hereof) of the City in
connection with the provision of Telecommunications Services (as defined in
Section 1 hereof including renewals thereof; and

      WHEREAS, the Company had submitted to DoITT its proposal in response to a
Request for Proposals issued by DoITT pursuant to Resolution No. 404 (adopted by
the New York City Council on March 26, 1992); and

      WHEREAS, on February 7, 2000 the FCRC held a public hearing on the
Company's petition for an amended and restated franchise to install cable, wire,
fiber optic telecommunications cable or other transmission medium that may be
used in lieu of cable, wire or fiber optic telecommunications cable for the same
purposes and related equipment and facilities on, over, and under the City's
Inalienable Property to be used in providing Telecommunications Services, which
was a full public proceeding affording due process in compliance with the
requirements of Chapter 14 of the City Charter; and

                                      -1-
<PAGE>

      WHEREAS, at said hearing, the FCRC reviewed the Company's financial, legal
and technical ability to carry out its obligations pursuant to this Agreement;
reviewed the Company's plan for constructing, operating, maintaining and
upgrading the System (as defined in Section 1 hereof); and determined that this
Agreement granting the Company a nonexclusive franchise complies with all
applicable City Laws and regulations; and

      WHEREAS, DoITT has reviewed the proposed action under the New York State
Environmental Quality Act ("SEQRA") (Section 8-010 et. seq.) of the New York
State Environmental Conservations Law), the SEQRA regulations set forth at Part
617 of Title 6 of the New York Code of Rules and Regulations, and the City
Environmental Quality Review ("CEQR") process (Chapter 5 of Title 62 and Chapter
6 of Title 42 of the Rules of the City of New York) and determined that this
action is properly classified as "Type II" action thereunder; and

      WHEREAS, the New York City Department of City Planning determined, as
evidenced in its letter dated April 23, 1992, that the proposed franchise would
have no land use impacts and that review pursuant to Section 197c of the New
York City Charter (the "City Charter") would not be necessary; and

      WHEREAS, the City intends to exercise the full scope of its municipal
powers, including both its police power and contracting authority, to promote
the public interest, to enhance the health, welfare and safety of the public,
and to stimulate commerce by assuring the widespread availability of reliable
high-capacity telecommunications services; and, in pursuit of these goals among
other purposes, desires to maximize the availability of such Telecommunications
Services and to develop innovative uses by the City and its institutions of such
Services.

      NOW, THEREFORE, in consideration of the foregoing clauses, which clauses
are hereby made a part of this Agreement, the mutual covenants and agreements
herein contained, and other good and valuable consideration, the parties hereby
covenant and agree as follows:

                           SECTION 1 -- DEFINED TERMS

      For purposes of this Agreement, the following terms, phrases, words, and
their derivatives shall have the meanings set forth in this Section, unless the
context clearly indicates that another meaning is intended.

      1.1. "Affiliated Person" means each Person who falls into one or more of
the following categories. (i) each Person having, directly or indirectly, a
Controlling Interest in the Company; (ii) each Person in which the Company has,
directly or indirectly, a Controlling Interest; (iii) each officer, director,
general partner, limited partner holding an interest of ten percent (10%) or
more, joint venturer or joint venture partner of the Company; and (iv) each
Person, directly or indirectly, controlling, controlled by or under common
Control with the Company; provided that "Affiliated Person" shall in no event
mean the City, any limited partner holding an interest of less than ten percent
(10%) of the Company or any creditor of the Company solely by virtue of its
status as a creditor and which is not otherwise an Affiliated Person.

                                      -2-
<PAGE>

      1.2 "Agreement" means this agreement, together with the Appendices
attached hereto and all amendments, modifications or renewals hereof or thereof.

      1.3 "City" means the City of New York or, as appropriate in the case of
specific provisions of this Agreement, any board, bureau, authority, agency,
commission, department or any other entity of the City of New York, or any
authorized officer, official, employee or agent thereof, or any successor
thereto.

      1.4 "Commissioner" means the Commissioner of DoITT, or his or her
designee, or any successor in function to the Commissioner.

      1.5 "Company" means METROMEDIA FIBER NETWORK NYC, INC., a corporation
organized and existing under the laws of the State of Delaware and authorized to
do business as a corporation in the State of New York, whose principal place of
business is located at 1 North Lexington Avenue, White Plains New York 10601.

      1.6 "Comptroller" means the Comptroller" means the Comptroller of the
City, the Comptroller's designee, or any successor in function to the
Comptroller.

      1.7 "Control" or of "Controlling Interest" in a Person means actual
working control whatever manner exercised, including, without limitation,
working control through ownership, management, debt instruments or negative
control, as the case may be, of such Person. A rebuttable presumption of the
existence of Control of or a Controlling Interest in a Person shall arise from
the beneficial ownership, directly or indirectly, by any Person, or group of
Persons acting in concert, of more than ten percent (10%) of such Person (which
Person or group of Persons is hereinafter referred to as "Controlling Person").
"Control" or "Controlling Interest" as used herein may be held simultaneously by
more than one Person or group of Persons.

      1.8 "Customer" means any Person lawfully receiving any Service provided by
the Company by means of the System.

      1.9 "DoITT" means the Department of Information Technology and
Telecommunications of the City of New York, or any successor thereto(1).

      1.10 "Effective Date" means the date this Agreement is fully executed and
delivered by the City and the Company.

      1.11 "FCC" means the Federal Communications Commission, or any successor
thereto.

      1.12 "FCRC" means the Franchise and Concession Review Committee of the
City of New York, or any successor thereto.

----------
(1)   Formerly the Department of Telecommunications and Energy ("DTE").

                                      -3-
<PAGE>

      1.13 "Fiber" means fiber optic telecommunications cable or other
transmission medium that may be used in lieu thereof for the same purposes.

      1.14 "Franchise Area" means the City of New York, unless a smaller area is
depicted in Appendix A to this Agreement.

      1.15 "Gross Revenue" shall include all revenue, as determined in
accordance with the generally accepted accounting principles, that is received
directly or indirectly by the Company or by any Affiliated Person from or in
connection with any Telecommunications Services provided in accordance with this
Agreement which originate in and/or terminate in the City (which shall include a
proportional allocation, which allocation shall be fair and equitable, of
revenues received by, or that should have been received by, the Company, any
Affiliated Person or any other Person for Service utilizing any part of the
System, provided, however, that such proportional allocation shall in no case be
less than the fair market value for such Service). The Company shall, within two
years following the Effective Date, submit to the City for the City's review and
approval the method by which such allocation is to be made, and such approval by
the City shall not be unreasonably withheld. If the City's decision become
subject to court review, the court shall undertake its review consistent with
the standards established in this Section 1.15. The revenues described in this
paragraph shall include, without limitation, the value of any free Services
provided by the Company (provided, however, that the value of any free Service
provided hereunder to the City pursuant to Section 7.1.1(b) or Appendix E or to
any other governmental entity shall not constitute Gross Revenue); the fair
market value of any nonmonetary transactions between the Company and any Person
other than an Affiliated Person, but not less than the customary prices paid in
connection with equivalent transactions, viewing all components of the
transactions taken as a whole, the fair market value of any nonmonetary
transactions between the Company and any Affiliated but not less than the
customary prices paid in connection with equivalent transactions, considering
the entirety of all transactions taken as a whole, conducted with Persons who
are not Affiliated Persons; and any revenue received by the Company or by any
Affiliated Person, as reasonably determined from time to time by the City,
through any means which is intended to have the effect of evading the payment of
compensation that would otherwise be paid to the City for the franchise granted
herein. Gross Revenue shall also include revenue derived from the sale or lease
of equipment and/or facilities provided by the Company or any Affiliated Person
if such facilities and/or equipment are required for and integrated with the
Services provided by the Company within the Franchise Area, except that Gross
Revenue shall not include revenue from the sale of customer equipment that is
readily available for sale in the consumer retail market. Gross Revenue shall
not include (i) actual payments received from interconnecting telecommunications
services providers outside the boundaries of New York City, for services
provided outside the boundaries of New York City; (ii) taxes collected to pay to
legitimate taxing authorities; (iii) any revenues that are already included in
the calculation of franchise fees payable to the City under any other franchise
agreement between (a) the City and (b) the Company or any Affiliated Person
provided that any services other than a "cable system" as defined in the Cable
Communications Policy Act of 1984 as amended 47 U.S.C ss. 522 et. seq., and/or
"mobile telecommunications services" as defined in the authorizing resolution
adopted by the Council on August 11, 1999 (Resolution 957) shall be considered
to be provided under the franchise granted herein; (iv) any free Services
required by this Agreement; (v) the revenue of any Person (including, without
limitation, a supplier of services) to the extent that such revenue is also
included in Gross Revenue of the Company; (vi)

                                      -4-
<PAGE>

the revenue of the Company of any Affiliated Person received directly from the
sale of any merchandise, goods or other non-Telecommunications Services that are
sold through any Service distributed over the System (other than that portion of
such revenue which represents or can be attributed to a customer fee or other
payment for the use of the System for the sale of such merchandise, goods or
non-Telecommunications Services, which portion shall be included in Gross
Revenue), provided, however, that the foregoing exclusion from Gross Revenue
shall in no way be deemed to exclude from Gross Revenue any revenue derived from
the sale or lease of equipment and/or facilities provided by the Company or any
Affiliated Person if such facilities and/or equipment are required for and
integrated with the Services provided by the Company; (vii) investment income;
(viii) the revenue of any Affiliated Person which represents standard and
reasonable amounts paid by the Company to the Affiliated Person for ordinary and
necessary business expenses of the Company, including, without imitation,
professional service fees and insurance or bond premiums; (ix) advertising
commissions deducted by advertising agencies before advertising revenues are
paid over to the Company; (x) any amount billed to customers and collected by
the Company or any Affiliated Person on behalf of any non-Affiliated Person who
is a telecommunications provider for services provided by such provider to such
customers where such amount is passed through in its entirety by the Company or
Affiliated Person to such provider; (xi) the value of any use of the System by
the Company or Affiliated Person for wholly owned internal administrative
purposes, including the distribution of cable programming from one Affiliated
Person to another Affiliated Person, provided that such Affiliated Persons are
substantially owned by the Company or its parent; (xii) to the extent consistent
with generally accepted accounting principles, consistently applied, bad debt
write-offs; and (xiii) the value of short-term promotional Services. With
respect to the Gross Revenue from customers receiving "resold" service (as
opposed to "facilities-based" service), Gross Revenue shall be reduced by the
amounts paid by the Company to the independent third party owner of the facility
(or facilities) through which such customers are being served, for such
facilities, services and equipment as are necessary to provide the resold
services to such customers (such amounts paid may include (if applicable under
the circumstances) for example, and without limitation, monthly service charges,
non-recurring charges, local and itemized call charges, enhanced service fees,
directory assistance fees and surcharges. For purposes of this Agreement "resold
services" shall include the sale of services by the Company using the fiber or
other transmission facilities of any independent third party.

      1.16 "Inalienable Property" means the rights of the City in and to its
waterfront, ferries, wharf property, bridges, land under water, public landings,
wharves, docks, streets, avenues, highways, parks, waters, waterways and all
other public places.

      1.17 "Initial Backbone" means the backbone depicted in Appendix O to this
Agreement.

      1.18 "Mayor" means the chief executive officer of the City, the Mayor's
designee, or any successor to the executive powers of the present Mayor.

      1.19 "Original Agreement" and "Original Agreement Date" have the meanings
set forth in the first paragraph of the preamble to this Agreement.

                                      -5-
<PAGE>

      1.20 "Person" means any natural person or any association, firm,
partnership, joint venture, corporation, or other legally recognized entity,
whether for profit or not for profit, but shall not mean the City.

      1.21 "PSC" means the New York State Public Service Commission, or any
successor thereto.

      1.22 (a) "Service" or "Telecommunications Service(s)" means any
telecommunications services provided by the Company within the Franchise Area
which the Company is authorized to provide under applicable federal, state and
local law, and any equipment and/or facilities required for and integrated with
the Services provided by the Company within the Franchise Area except as
excluded in paragraphs (b) or (c)(i) below.

            (b) "Service" or "Telecommunications service(s)" do not include (i)
a "cable service" as defined in Cable Communications Policy Act of 1984, (47
U.S.C. ss.522 et. seq.) (ii) "mobile telecommunication services" as defined in
the authorizing resolution adopted by the New York City Council on July 19, 1994
(Resolution No. 438), and (iii) the installation or operation of public pay
telephones as defined in the authorizing resolution adopted by the New York City
Council on March 25, 1997 (Resolution No. 2248), (iv) other telecommunications
activities requiring the installation or operation of street furniture or (v)
open video service as described in 47 U.S.C. ss. 573.

            (c) (i) "Service" or "Telecommunications service(s)" shall not
include the providing or leasing of Fiber capacity by the Company to either (x)
any related entity providing "mobile telecommunications services" or (y) any
related or unrelated entity providing "cable service" (as defined in 47 U.S.C.
ss.522) unless such entity has a franchise from the City for the provision of
"mobile telecommunications services", "cable service" or an agreement to provide
an open video system (as described in 47 U.S.C. and in the rules and regulations
promulgated thereunder).

                  (ii) "Service" or "Telecommunications Service(s)" shall
include the providing or leasing of Fiber capacity by the Company to any
unrelated entity providing "mobile telecommunications services".

            (d) For purposes of this definition, a related entity is an entity
(i) which, directly or indirectly, owns a beneficial interest of 10% or more in
the Company, or (ii) in which the Company, directly or indirectly, a common
owner of a beneficial interest of 10% or more in each, or (iv) which is an
Affiliated Person, or (v) which is otherwise related to the Company in a manner
similar, or to an extent comparable, to the relationships described in the
proceeding clauses (i) through (iv).

            (e) For the purposes of this definition, an unrelated entity means
an entity which is not a related entity.

      1.23 "Signal" means any transmission of electronic, electrical or radio
frequency energy or optical information.

                                      -6-
<PAGE>

      1.24 "System" or "Telecommunications System" means the telecommunications
system which is to constructed, operated and maintained by the Company pursuant
to this Agreement, including, without limitation, all real property and
interests in real property, all tangible and intangible personal property,
buildings, offices, furniture, Customer lists, cables, wires, optical fibers,
amplifiers and all other electronic devices, equipment and facilities used in
connection therewith, and all rights, contracts and understandings with regard
to any matter related thereto.

                         SECTION 2 -- GRANT OF AUTHORITY

      2.1 Term

            This Agreement, and the franchise granted hereunder, shall commence
upon the Effective Date, and shall continue for a period of fifteen (15) years
from the Original Agreement Date, unless this Agreement is earlier terminated
upon the earliest to occur of: (a) a revocation of the franchise, as provided by
Section 11.3 hereof, or (b) the expiration of the term of the franchise by
acceleration, or otherwise. The period of time that this Agreement remains in
effect is herein referred to as the "Term".

      2.2 Conditions to Execution

            2.2.1 Certain Actions by the Company Before Execution

                  Prior to the execution of this Agreement, the Company has
satisfied certain conditions to the City's execution of this Agreement by
delivering to DoITT the following: (a) evidence that it has deposited with the
Comptroller the Performance Bond/Security Fund required pursuant to Section 5.8
hereof; (b) a certificate of liability insurance, pursuant to Section 10.2
hereof, with a copy to the Comptroller; (c) an opinion of the Company's counsel
dated as of the Effective Date opining that this Agreement has been duly
authorized, executed and delivered by the Company and is a binding obligation of
the Company and opining as to such other matters as the City has requested; (d)
the questionnaires required in connection with the City's Vendor Information
Exchange System ("VENDEX"); (e) evidence that the Company has paid the initial
portion of its pro rata share of the City's franchising cost pursuant to Section
7.2.1 herein; and (f) certified copies of the Company's organizational and
governing documents, as amended to date, pursuant to Section 13.6[ILLEGIBLE]
herein.

            2.2.2 Vendex

                  Favorable completion of the City's appropriate review in
connection with Vendex shall be a condition to the City's execution of this
Agreement.

      2.3 Nature of Franchise, Effect of Termination and Renewal

            2.3.1 Nature of Franchise

                  (a) The City hereby grants the Company, subject to the terms
and conditions of this Agreement, a nonexclusive franchise providing the right
and consent to

                                      -7-
<PAGE>

      install, operate, repair, maintain, remove and replace cable, wire, Fiber
      or other transmission medium that may be used in lieu of cable, wire or
      Fiber for the same purposes and related equipment and facilities on, over
      and under the Inalienable Property of the City in order to provide
      Telecommunications Services which originate and/or terminate in or transit
      the Franchise Area.

                  (b) The Telecommunications Services the Company intends (as of
      the Effective Date) to offer and the Telecommunications Systems the
      Company intends (as of the Effective Date) to construct, operate and
      maintain, are set forth on Appendix D to this Agreement.

                  (c) Before offering or providing any Telecommunications
      Services pursuant to this franchise, the Company shall obtain any and all
      regulatory approvals, permits, authorizations or licenses for the offering
      or provision of such Telecommunications Services from the appropriate
      federal, state and local authorities, if required, and shall submit to
      DoITT upon the written request of the City evidence of all such approvals,
      permits, authorizations or licenses.

            2.3.2 Effect of Termination

                  Upon termination of this Agreement, the franchise shall
expire; all rights of the Company in the franchise shall cease, with no value
allocable to the franchise itself; and the rights of the City and the Company to
the System, or any part thereof, shall be determined as provided in Sections
11.3 through 11.6 hereof. The termination of this Agreement and the franchise
granted hereunder shall not, for any reason, operate as a waiver or release of
any obligation of the Company or any other Person, as applicable, for any
liability (i) pursuant to Section 10.1 hereof, which arose or arises out of any
act or failure to act required hereunder prior to the termination; (ii) which
exists pursuant to Sections 7, "Compensation," 8.7.2, "Right of Inspection,"
11.3 through 11.6, "Termination," 13.14, "Governing Law," and 13.17, "Claims
under Agreement," hereof; and (iii) to maintain in full force and effect the
Performance Bond/Security Fund and coverage under the liability insurance
policies required under and in accordance with Sections 5.8 and 10.2 hereof.

            2.3.3 Renewal

                  This Agreement does not grant to the Company any right to
renewal of this Agreement or the franchise granted hereunder, and there shall be
no such right. The Company may submit a written petition to the City to renew
this Agreement and the franchise granted hereunder not later than twelve (12)
months nor more than eighteen (18) months before the expiration of the Term.
Nonetheless, the City shall not be obligated to renew this Agreement or the
franchise granted hereunder.

      2.4 Conditions and Limitations on Franchise

            2.4.1 Not Exclusive

                  Nothing in this Agreement shall affect the right of the City
to grant to any Person a franchise, consent or right to occupy and use
Inalienable Property of the City, or any

                                      -8-
<PAGE>

part thereof, for the construction, operation and/or maintenance of a system to
provide telecommunications services in the City for any purpose, or the right of
the City to construct, operate and/or maintain a system to provide
telecommunications services in the City or to acquire and operate the System
pursuant to this Agreement, except that the City shall not use any Services,
equipment, cable, wire, Fiber or other transmission medium provided by the
Company pursuant to this Agreement to sell to non-governmental entities in
competition with the Company.

            2.4.2 Construction of System.

                  (a) The Company is authorized to install the System, including
      cable, wire, Fiber or other transmission medium that may be used in lieu
      of cable, wire or Fiber for the same purposes, or related equipment and
      facilities at any location on, over or under the Inalienable Property of
      the City within the Franchise Area at any time during the Term, without
      further approval of DoITT, subject to the terms and conditions of this
      Agreement. The Company shall use its best efforts to coordinate its
      construction schedule with the appropriate City agencies, including,
      without limitation, the appropriate Borough Engineer and the Office of
      Construction, to minimize unnecessary disruption.

                  (b) The Company agrees to commence construction of the Initial
      Backbone as soon as feasible after the Original Agreement Date and in any
      event no later than six (6) months after the Original Agreement Date,
      subject to the timely issuance of necessary permits and licenses, which
      will be diligently pursued by the Company. The Company agrees to
      substantially complete the installation of the Initial Backbone within
      twenty-four (24) months after the date of commencement of construction of
      the Initial Backbone, subject to the timely issuance of necessary permits
      and licenses, which will be diligently pursued by the Company.

                  (c) The Company shall obtain all construction, building or
      other permits or approvals necessary before installing such cable, wire,
      Fiber or other transmission medium that may be used in lieu of cable, wire
      or Fiber for the same purposes, or related equipment and facilities. The
      Company shall provide copies of any such permits and approvals to DoITT
      upon request.

            2.4.3 Public Works and Improvements

                  Nothing in this Agreement shall abrogate the right of the City
to perform any public works or public improvements of any description. In the
event that the System interferes with the construction, operation, maintenance,
repair or removal of such public work or public improvements, the Company shall,
at its own cost and expense (unless, dedicated funds have been provided to the
City specifically for such purpose), upon reasonable notice from the City,
promptly protect or alter or relocate the System, or any part thereof, as
directed by the City. In the event that the Company refuses or neglects to so
protect, alter or relocate all or part of the System, the City shall have the
right, upon notice by the City, to break through, remove, alter, relocate all or
any part of the System without any liability to the Company, and the Company
shall pay to the City the costs incurred in connection with such breaking
through, removal, alteration, or relocation.

                                      -9-
<PAGE>

            2.4.4 No Waiver

                  Nothing in this Agreement shall be construed as a waiver of
any codes, ordinances or regulations of the City or of the City's right to
require the Company or Persons utilizing the System to secure the appropriate
permits or authorizations for such use, provided that no fee or charge may be
imposed upon the Company for any such permit or authorization, other than the
standard fees or charges generally applicable to all Persons for such permits or
authorizations. Any such standard fee or charge shall not be an offset against
the compensation the Company is required to pay to the City pursuant to Section
7 of this Agreement.

            2.4.5 No Release

                  Nothing in this Agreement shall be construed as a waiver or
release of the rights of the City in and to the Inalienable Property of the
City. In the event that all or part of the Inalienable Property within the
Franchise Area is eliminated, discontinued, closed or demapped, all rights and
privileges granted pursuant to this Agreement with respect to said Inalienable
Property, or any part thereof so eliminated, discontinued, closed or demapped,
shall cease upon the effective date of such elimination, discontinuance, closing
or demapping. If said elimination, discontinuance, closing or demapping is
undertaken for the benefit of any private Person, the City shall make reasonable
efforts to condition its consent to said elimination, discontinuance, closing or
demapping on the agreement of said private Person to (i) grant the Company the
right to continue to occupy and use said Inalienable Property or (ii) reimburse
the Company for the reasonable costs of relocating the affected part of the
System.

      2.5 Renegotiation of Agreement

                  (a) Each party shall have the right, any one time following
      the date seven (7) years after the Original Agreement Date and upon six
      (6) months notice to the other party, to require the renegotiation of the
      terms of Sections 7 and 8 hereof based on changes in technological, legal,
      regulatory or market conditions that have occurred since the Effective
      Date, provided, however, that any renegotiated terms shall apply only
      prospectively to any contracts entered into by the Company with customers
      following the effective date of the renegotiated terms. The parties shall,
      during renegotiation of said Sections under this Section 2.5, negotiate in
      good faith.

                  (b) If, despite such good faith negotiations, the parties fail
      to reach an agreement that is reasonably acceptable to both parties within
      a reasonable period, then either party shall have the right, by notice to
      the other, that the term of this Agreement and the franchise granted
      hereunder shall be accelerated and shall terminate on the date which is
      one half of the number of days between the date of such notice and the
      fifteenth anniversary of the Original Agreement Date.

                  (c) The parties' rights pursuant to this Section 2.5 shall be
      cumulative and shall be in addition to and not in derogation of all other
      rights reserved under other provisions of this Agreement.

                                      -10-
<PAGE>

                              SECTION 3 -- SERVICE

      3.1 No Interference

            In the operation of the System, the Company shall not interfere with
the technical operation of any other telecommunications system in the City.

      3.2 No Monopoly

            If, at any time during the Term, it is finally determined by a court
of competent jurisdiction (not subject to further appeal) that the distribution
or provision of any Service in the Franchise Area by the Company or any
Affiliated Person, or any other action in connection with the operation of the
System, has tended to create or has created a monopoly or a restraint of trade
in violation of law, such determination shall be deemed to be an Event of
Default under this Agreement. In such event, in addition to pursuing any of the
actions set forth in Section 11.2 hereof, DoITT may issue a directive to correct
such conditions, consistent with this Agreement and the determination of the
court, without following the procedural requirements of Sections 11.2.2 and
11.2.3 hereof.

      3.3 No Discrimination

            The Company shall not discriminate in the provision of Services on
the basis of race, creed, color, national origin, sex, age, handicap, marital
status, or real or perceived sexual orientation.

      3.4 Service

            The Company agrees to market its Services on the System throughout
the Term. In the event the Company, with the consent of the City, sells or
otherwise transfers the System Control thereof to any Person, the City or the
City's assignee, or in the event the franchise terminates, the Company shall
transfer the System in an orderly manner in order to maintain continuity of
Service to the City and to other Customers.

                           SECTION 4 - TARIFF FILINGS

      4.1 Tariffs

            The Company shall from time to time at the reasonable request of the
City provide the City with a copy of any tariff filed by the Company with
respect to any services offered in the Franchise Area and provide a reasonable
response to any City request for an explanation of the nature or applicability
of such tariff.

                                      -11-

<PAGE>

              SECTION 5 -- CONSTRUCTION AND TECHNICAL REQUIREMENTS

      5.1 General Requirement

            The Company agrees to comply with each of the terms set forth in
this Section governing construction and technical requirements for its System,
in addition to any other requirements or procedures specified by the
Commissioner and which are not inconsistent with any express provision of this
Agreement.

      5.2 Quality

            All work involved in the construction, operation, maintenance,
repair, upgrade and removal of the System shall be performed in a safe, thorough
and reliable manner using materials of good and durable quality. If, at any
time, it is reasonably determined by the City or any other agency or authority
of competent jurisdiction that nay part of the System, including, without
limitation, any means used to distribute Signals over or within the System, is
harmful to the public health or safety, then the Company shall, at its own cost
and expense, take all steps necessary to correct all such conditions.

      5.3 Licenses and Permits

            The Company shall have the sole responsibility for diligently
obtaining, at its own cost and expense, all permits, licenses or other forms of
approval or authorization necessary to construct, operate, maintain, upgrade or
repair the System, including but not limited to any necessary approvals from
Persons to use private property, easements, poles and conduits. The Company
shall obtain any required permit, license, approval or authorization prior to
the commencement of the activity for which the permit, license, approval or
authorization is required.

      5.4 Relocation of the System

            5.4.1 New Grades or Lines

                  If the grades or lines of any Inalienable Property within the
Franchise Area are changed at any time during the Term in a manner affecting the
System, then the Company shall, at its own cost and expense, and upon reasonable
notice by the City, promptly protect or promptly alter or relocate the System,
or part thereof, so as to conform with such new grades or lines. In the event
that the Company unreasonably refuses or neglects to so protect, alter or
relocate all or part of the System, the City shall have the right to break
through, remove, alter or relocate such part of the System without any liability
to the Company, and the Company shall pay to the City the costs incurred in
connection with such breaking through, removal, alteration or relocation.

            5.4.2 City Authority to Move Wires

                  The City may, at any time, in case of fire, disaster or other
emergency, as determined by the City in its reasonable discretion, cut or move
any other optical fibers, wires, cable, amplifiers, appliances or other parts of
the System on, over or under the Inalienable

                                      -12-
<PAGE>

Property of the City, in which event the City shall not be liable therefor to
the Company. The City shall notify the Company in writing prior to, if
practicable, but in any event as soon as possible and in no case later than the
next business day following any action taken under this Section 5.4.2.

            5.4.3 Company Required to Move Wires

                  The Company shall, upon prior written notice by the City or
any Person holding a permit to move any structure, and within the time that is
reasonable under the circumstances, temporarily move its wires to permit the
moving of said structure. The Company may impose a reasonable charge on any
Person other than the City for any such movement of its wires.

      5.5 Protect Structures

            In connection with the construction, operation, maintenance, repair,
upgrade or removal of the System, the Company shall, at its own cost and
expense, protect any and all existing structures belonging to the City and all
designated landmarks, as well as all other structures within any designated
landmark district. The Company shall obtain the prior approval of the City
before altering any water main, sewerage or drainage system, or any other
municipal structure on, over or under the Inalienable Property of the City
required because of the presence of the System. Any such alteration shall be
made by the Company, at its own cost and expense and in a manner prescribed by
the City. The Company agrees that it shall be liable, at its own cost and
expense, to replace or repair and restore to its prior condition in a manner as
may be reasonably specified by the City, any municipal structure or any other
Inalienable Property of the City involved in the construction, operation,
maintenance, repair, upgrade or removal of the System that may become disturbed
or damaged as a result of any work thereon by or on behalf of the Company
pursuant to this Agreement.

      5.6 No Obstruction

            In connection with the construction, operation, maintenance,
upgrade, repair or removal of the System, the Company shall not unreasonably
obstruct the inalienable Property of the City, subways, railways, passenger
travel, river navigation, or other traffic to, from or within the Franchise Area
without the prior consent of the appropriate authorities..

      5.7 Safety Precautions

            The Company shall, at its own cost and expense, undertake all
necessary and appropriate efforts to prevent accidents at its work sites,
including the placing and maintenance of proper guards, fences, barricades,
security personnel and suitable and sufficient lighting.

      5.8 Performance Bond/Security Fund

            5.8.1 General Requirements

                  Prior to the execution of this Agreement, the Company shall
have deposited with the Comptroller an irrevocable, unconditional letter of
credit and surety bond

                                      -13-
<PAGE>

which together total two million dollars ($2,000,000). Such $2,000,000
constitutes the Company's Performance Bond/Security Fund. A minimum of one
million dollars ($1,000,000) of this amount shall be in the form of a surety
bond, and the Company may, at it discretion, further increase the proportion of
the Performance Bond/Security Fund that is in the form of a surety bond so long
as at least two hundred fifty thousand dollars ($250,000) of the Performance
Bond/Security fund remains in the form of a letter of credit. The total amount
of the Performance Bond/Security Fund may be reduced to one million dollars
($1,000,000), which must consist of at least a two hundred fifty thousand dollar
($250,000) letter of credit, following the date 30 days after completion by the
Company of the Initial Backbone. Throughout the Term, and for one hundred twenty
(120) days thereafter, unless the City notifies the Company that a reasonable
longer period shall apply, the company shall maintain the Performance
Bond/Security Fund in the amount specified in this Section 5.8. At any time
during the Term, the City may, acting reasonably, require the Company to
increase the amount of the Performance Bond/Security Fund if it finds that new
risk factors exist, such as an increase in the amount of compensation payments
to be made pursuant to Section 7.1 hereof or the failure of the Company to
perform any of its obligations pursuant to Section 7.1 hereof or the failure of
the Company to perform any of its obligations pursuant to this Agreement, which
reasonably necessitate an increase in the amount of the Performance
Bond/Security Fund.

            5.8.2 Indemnification

                  The Performance Bond/Security Fund shall indemnify the City,
up to the full face amount of the Performance Bond/Security Fund, for: (i) the
cost to continue any construction of the portion of the System being constructed
for the City pursuant to Section 7.1.1(b) herein and Appendix E hereof; (ii) the
cost of maintaining operation of the System following a termination of this
Agreement as a result of a default by the Company, pursuant to Section 11.3
hereof, in excess of all net revenue actually received through the continued
operation of the System during said period; (iii) any loss or damage to any
municipal structure or other Inalienable Property of the City during the course
of any construction of the System; (iv) any other costs, or loss or damage
actually incurred by the City as a result of the Company's failure to perform
its obligations pursuant to this Agreement; and (v) the removal of all or any
part of the System from the Inalienable Property of the City, as authorized by
this Agreement.

            5.8.3 Other Purposes

                  The Performance Bond/Security Fund shall also serve as
security for:

                  (a) the faithful performance by the Company of all terms,
      conditions and obligations of this Agreement;

                  (b) any expenditure, damage, or loss incurred by the City
      occasioned by the Company's failure to comply with all rules, regulations,
      orders, permits and other directives of the City and the Commissioner
      issued pursuant to this Agreement;

                  (c) payment of compensation set forth in Section 7 hereof;

                  (d) the payment of premiums for the liability insurance
      required pursuant to Section 10 hereof;

                                      -14-
<PAGE>

                  (e) the removal of the System from the Inalienable Property of
      the City at the termination of the Agreement; at the election of the City,
      pursuant to Section 11.4 hereof;

                  (f) the Payment to the City of any amounts for which the
      Company is liable pursuant to Section 10.1.1 hereof which are not paid by
      the Company's insurance;

                  (g) the payment of any other amounts which become due to the
      City pursuant to this Agreement or law;

                  (h) the timely renewal of the letter of credit that
      constitutes the Performance Bond/Security Fund; and

                  (i) any costs, losses or damages incurred by the City as a
      result of a default of the Company's obligations under this Agreement.

            1.1.4 Withdrawals from the Performance Bond/Security Fund

                  In accordance with the procedures set forth in Sections 5.8.5,
11.2 and 11.3, the Comptroller, upon the direction of the Commissioner, may make
withdrawals from the Performance Bond/Security Fund and pay to the City such
amount for the satisfaction of obligations under Section 5.8.2 hereof, or for
the purposes specified in Section 5.8.3 hereof. Withdrawals from the Performance
Bond/Security Fund shall not be deemed a cure of the default(s) that led to such
withdrawals. The City may not seek recourse against the Performance
Bond/Security Fund for any costs or damages for which the City has previously
been compensated through a withdrawal from the Performance Bond/Security Fund or
otherwise by the Company.

            5.85 Notice of Withdrawals

                  Within one (1) week after any withdrawals from the Performance
Bond/Security Fund, the Comptroller shall notify the Company of the date and
amount thereof, provided, however, that the City shall not make any withdrawals
by reason of any breach for which the company has not been given notice. The
withdrawal of amounts from the Performance Bond/Security Fund shall constitute a
credit against the amount of the applicable liability of the Company to the City
but only to the extent of said withdrawal.

            5.86 Replenishment

                  Within thirty (30) days after receipt of notice from the
Comptroller that any amount has been withdrawn from the Performance
Bond/Security Fund letter of credit, as provided in Section 5.8 hereof, the
Company shall restore the Performance Bond/Security Fund to the amount specified
in Section 5.8.1 hereof, provided that, if a court finally determines that said
withdrawal by the City was improper, the City shall refund the improperly
withdrawn amount to the Performance Bond/Security Fund or to the Company such
that the balance in the Performance Bond/Security Fund shall not exceed the
amount specified in Section 5.8.1 hereof. In case of such an improper
withdrawal, the Company shall receive any interest accrued on the amount
improperly withdrawn from the time of withdrawal to the time of refund to the
Fund. If

                                      -15-
<PAGE>

the Company has not made the required restoration to the Performance
Bond/Security Fund within such thirty (30) day period, interest on said amount
shall accrue at the rate specified in Section 7.4 hereof, to commence at the
completion of such 30-day period. The Comptroller may withdraw from the
Performance Bond/Security Fund and pay to the City such interest periodically up
to the date on which the Company makes the required principal payment, provided
that the Company shall not be obligated to pay such interest with such principal
payment to the extent such interest has been already withdrawn by the
Comptroller.

            5.8.7 Not a Limit on Liability

                  The obligation to perform and the liability of the Company
pursuant to this Agreement shall not be limited by the acceptance of the
Performance Bond/Security Fund required by this Section 5.8.

            5.8.8 Form

                  The Performance Bond/Security Fund does, and any replacement
bond shall, contain the following endorsement: "It is hereby understood and
agreed that this bond may not be cancelled or not renewed by the surety nor the
intention to cancel or not to renew be stated by the surety until ninety (90)
days after completion of construction of the Initial Backbone and
notwithstanding the foregoing, shall in no case be cancelled or not renewed by
the surety until at least ninety (90) days' written notice is given to the City
of surety's intention to cancel or not renew this bond." Notwithstanding the
preceding, the letter of credit portion of the Performance Bond/Security Fund
shall not be cancelled or not renewed by the issuer until at least sixty (60)
days' notice to the City of the issuer's intention to cancel or not renew the
letter of credit.

                     SECTION 6 -- EMPLOYMENT AND PURCHASING

      6.1 Right to Bargain collectively

            The Company agrees to recognize the right of its employees to
bargain collectively through representatives of their own choosing in accordance
with applicable law. The Company shall recognize and deal with the
representatives duly designated or selected by a majority of its employees for
the purpose of collective bargaining with respect to rates of pay, wages, hours
of employment or any other terms, conditions or privileges of employment. The
Company shall not dominate, interface with, participate in the management or
control of, or give financial support to any union or association of its
employees.

      6.2 Local Preference

            The company shall, at its own cost and expense, develop and maintain
a plan for the recruitment, education, training and employment of residents of
the City, for the opportunities to be created by the construction, operation,
marketing and maintenance of the System. Such recruitment activities shall
include provisions for the posting of employment and training opportunities at
appropriate City agencies responsible for encouraging employment of City
residents. Such plan shall be designed so as to ensure the promotion of equal
employment opportunity for all qualified Persons employed by, or seeking
employment with, the Company.

                                      -16-
<PAGE>

Such plan shall be updated from time to time as the City deems reasonably
necessary. The Company shall, throughout the Term, implement such plan at its
own cost and expense, by ensuring, to the maximum feasible extent, the
recruitment, education, training, and employment of City residents.

      6.3 City Vendors

            To the maximum feasible extent, after taking into account price and
quality considerations, the Company shall utilize vendors located in the City in
connection with the construction, operation, marketing and maintenance of the
System. The Company shall, after taking into account price and quality
considerations, in the purchase of comparable materials, equipment, services or
supplies of any nature, give effect to a preference for such items which are
assembled, manufactured, or otherwise produced, in whole or in part, within the
City.

      6.4 Equal Employment Opportunity

            The Company agrees to comply in all respects with the provisions of
the Mayor's Executive Order No. 50 (April 25, 1980) (codified at Title 10
Sections 1-14 of the Rules of the City of New York) and City Administrative Code
6-108.1 (1984) and all rules and regulations promulgated thereunder
collectively, the "EEO Requirements"), as such EEO Requirements may be amended,
modified or superseded throughout the Term. Notwithstanding that the EEO
Requirements may not apply on their face to the Company as a franchisee of the
City, the Company shall comply in all respects with the provisions of such EEO
Requirements and successor and replacement laws, orders and regulations adopted
following the Effective Date. As required by said Executive Order No. 50, the
provisions of Sections 50.30 and 50.31 of the Final Rule implementing said Order
are incorporated herein by this reference. The Company agrees to make a
reasonable inquiry and to engage in reasonable compliance monitoring efforts
with all unions to ensure that all contractors and subcontractors comply with
the required contractual language in Section 6.5. The Company shall not contract
with and shall discontinue any contract entered into after the Effective Date
with any union, contractor or subcontractor that refuses to agree to or fails to
comply with the contractual language in Section 6.5.

      6.5 Local law 33

            The Company agrees to comply in all respects with the provisions of
the Local Law 33 of 1997 and all rules or regulations promulgated thereunder, as
such law and all rules or regulations may be amended, modified or succeeded
throughout the term. Notwithstanding that Local Law 33 may not apply on its face
to the company as a franchisee of the City, the Company shall comply in all
respects with the provisions of such Law and rules or regulations and successor
and replacement laws, and rules or regulations adopted following the Effective
Date.

      6.6 Enforcement

            The Company shall take steps to ensure that the requirements of
Section 6.4 hereof are adhered to by each union with which the company deals,
each officer, employee, agent, contractor or subcontractor of the Company, and
each Person performing work pursuant to this Agreement with respect to the
System for, on behalf of, or at the discretion of the Company.

                                      -17-
<PAGE>

The requirements of Section 6.4 hereof shall apply to every contract relating to
the System between the Company and: (i) any union; (ii) any contractor; (iii)
any subcontractor; or (iv) any Person with which any of the foregoing Persons
has a relationship in connection with any aspect of the System. To comply with
the obligations of this Section 6.6, the Company shall include, in all contracts
described in the foregoing sentence which are entered into following the
Effective Date (which shall include any renewals, amendments and modifications
of existing contracts), the following language, stating that such party: "has
received a copy of Section 6 of a certain agreement by and between the City of
New York and the Company dated as of _______, 2000, granting to the Company a
nonexclusive franchise providing the right and consent to install cable, wire,
Fiber or other transmission medium that may be used in lieu of cable, wire or
Fiber for the same purposes and related equipment and facilities on, over and
under the Inalienable Property of the City within the Franchise Area to provide
Telecommunications Services and agrees to comply with each term, condition and
requirement of Section 6 of such agreement, which terms, conditions and
requirements are deemed to be incorporated herein by this reference."

                  SECTION 7 -- COMPENSATION AND OTHER PAYMENTS

      7.1 Compensation

            7.1.1 Compensation

                  As compensation for the franchise, the Company shall have the
following obligations:

                  (a) Franchise Fee. The Company's obligation to pay franchise
      fees shall commence on the Completion Date. For purposes of this Section
      7.1, the Completion Date shall be the earlier of the date of completion of
      the Initial Backbone or the second anniversary of the Original Agreement
      Date. Commencing on the Completion Date, the Company shall pay to the City
      five percent (5%) of Gross Revenue each year during the Term.

                        During each year of the Term following the Completion
      Date, the Company's compensation payments pursuant to this Section
      7.1.1(a) shall not be less than $200,000.00 (two hundred thousand dollars)
      per annum. Such minimum payment, however, shall be prorated if necessary
      to reflect a partial first or last year of the franchise. To the extent
      that the sum of all payments pursuant to this Section 7.1.1(a) with
      respect to any year is less than said minimum payment, then the Company's
      compensation payment to be made within forty-five (45) days of the last
      day of December of said year pursuant to Section 7.1.2 shall include an
      amount which brings the total amount paid with respect to said year up to
      said minimum payment.

                  (b) Services to City. The Company shall provide Services to
      the City, and observe its other obligations, as specified in Appendix E to
      this Agreement. The Company expressly acknowledges and agrees that neither
      the provision of Services to the City nor the satisfaction of other
      obligations specified in Appendix E to this Agreement

                                      -18-
<PAGE>

shall be chargeable against the franchisee fees to be paid to the City by the
Company pursuant to Section 7.1.1(a) hereof.

            7.1.2 Timing

                  (a) All payments made pursuant to Section 7.1.1(a) hereof
      shall be made on a quarterly basis within forty-five (45) days of the
      close of each calendar quarter. The Company shall in good faith estimate
      each quarterly payment based on anticipated revenues for that quarter.

                  (b) Within sixty (60) days following the end of the calendar
      year, the Company shall calculate the exact fee due to the City pursuant
      to section 7.1.1(a) hereof for said calendar year. Should the total
      calculated franchise fee for the year exceed the estimated quarterly
      payments made by the Company for the year, the Company shall, within the
      60-day period following the end of the calendar year, remit to the City
      any balance due. Should the estimated quarterly payments made by the
      Company for the year exceed the total calculated franchise fee for the
      year, the City will remit the overpayment within thirty (30) days
      following notice form the Company of the balance due.

                  (c) In no case shall the estimated quarterly payments to be
      paid pursuant to paragraph (a) of this Section 7.1.2 be less than
      one-forth (1/4) of the total calculated franchise fee based on Section
      7.1.1(a) thereof for the preceding calendar year.

            7.1.3 Records and Audits

                  The Company shall keep comprehensive itemized records of all
revenues received and of all Services provided, in sufficient detail to enable
the City to determine whether all compensation owed to the City pursuant to
Section 7.1 is being paid to the City.

            7.1.4 Reservation of Rights

                  No acceptance of any compensation payment by the City shall be
construed as an accord and satisfaction that the amount paid is in fact the
correct amount, nor shall such acceptance of any payment be construed as a
release of any claim that the City may have for further or additional sums
payable under the provisions of this Agreement. All amounts paid shall be
subject to audit and recomputation by the City.

            7.15 Ordinary Business Expense

                  Nothing contained in this section 7.1 or elsewhere in this
Agreement is intended to prevent the company from treating the compensation and
other payments that it may pay pursuant to this Agreement as an ordinary expense
of doing business and, accordingly, form deducting said payments from gross
income in any City, state, or federal income tax return.

                                      -19-
<PAGE>

      7.2 Other Payments

            7.2.1 Franchising Costs

                  The company has, prior to the execution of this Agreement,
paid a portion of the Company's pro rata share of costs incurred by the City for
the services of third parties (including, without limitation, attorneys and
other consultants) in connection with the award of this franchise. Within thirty
(30) days after receipt of an itemized and detailed invoice for services
rendered, the Company shall pay to DoITT, or at the direction of the
Commissioner to third party, the company's pro rata share of all remaining
reasonable costs and expenses incurred by the City for the services of third
parties (including, without limitation, attorneys and other consultants) in
connection with the award of this franchise. The company expressly agrees that
the payments referred to in this Section 7.2.1 are in addition to and not in
lieu of, and shall not be offset against, the compensation to be paid to the
City by the Company pursuant to Section 7.1 hereof.

            7.2.2 Future Costs

                  7.2.3 The Company shall pay to the City or to third parties,
at the direction of the commissioner, an amount equal to the reasonable costs
and expenses which the City incurs for the services of third parties (including
but not limited to attorneys and other consultants) in connection with any
renewal or Company-initiated renegotiation, transfer, amendment or other
modification of this Agreement or the franchise, provided, however, that in the
case of renewal only, the parties shall agree upon a reasonable financial cap at
the outset of negotiations. The Commissioner shall review the contested charges
and the services rendered and shall reasonably determine whether such charges
are reasonable for the services rendered. The Company expressly agrees that the
payments made pursuant to this Section 7.2 are in addition to and not in lieu
of, and shall not be offset against, the compensation to be paid to the City by
the Company pursuant to Section 7.1 hereof.

            7.3 No Credits or Deductions

                  (a) The Company expressly acknowledges and agrees that:

                        (i) The compensation and other payments to be made or
            Services to be provided pursuant to this Section 7 shall not be
            deemed to be in the nature of a tax, and shall be in addition to any
            and all taxes or other fees or charges which the Company or any
            Affiliated Person shall be required to pay to the City or to any
            state or federal agency or authority, all of which shall be separate
            and distinct obligations of the Company; and

                        (ii) The Company expressly relinquishes and waives its
            rights and the rights of any Affiliated Person to a deduction or
            other credit pursuant to Section 626 of the New York State Real
            Property Tax Law and any successor or amendment thereto, and to any
            subsequent law, rule, regulation, or order which would purport to
            permit any of the acts prohibited by this Section 7.3; and

                                      -20-

<PAGE>

                        (iii) Except as might be permitted by Section 7.1.5, the
            Company shall not, and shall not otherwise support any attempt by an
            Affiliated Person to make any claim for any deduction or other
            credit of all or any part of the amount of the compensation or other
            payments to be made or Services to be provided pursuant to this
            Agreement from or against any City or other governmental taxes of
            general applicability or other fees or charges which the Company or
            any Affiliated Person is required to pay to the City or other
            governmental agency; and

                        (iv) Except as might be permitted by Section 7.1.5, the
            Company shall not, and shall not otherwise support any attempt by an
            Affiliated Person to apply or seek to apply all or any part of the
            amount of the compensation or other payments to be made or Services
            to be provided pursuant to this Agreement as a deduction or other
            credit from or against any City or other government taxes of general
            applicability (other than income taxes) or other fees or charges,
            each of which shall be deemed to be separate and distinct
            obligations of the Company and the Affiliated Persons.

                  (b) In any situation where the Company believes the effect of
      this Section 7.3 is unduly harming, in a manner inconsistent with the
      intent of this Section 7.3, an Affiliated Person of the Company, the
      Company may petition the City for relief, and such relief shall not be
      unreasonably withheld.

      7.4 Interest on Late Payments

            In the event that any payment required by this Agreement is not
actually received by the City on or before the applicable date fixed in this
Agreement, interest thereon shall accrue from such date until received at a rate
equal to the rate of interest then in effect charged by the City for late
payments of real estate taxes.

      7.5 Method of Payment

            Except as provided elsewhere in this Agreement, all payments made by
the Company to the City pursuant to this Agreement shall be made to the City's
Department of Finance, with a copy to DoITT.

                                      -21-
<PAGE>

      7.6 Continuing Obligation and Holdover

                  (a) In the even the Company continues to operate all or any
      part of the System after the Term, then the Company shall continue to
      comply with all applicable provisions of this Agreement, including,
      without limitation, all compensation and other payment provisions of this
      Agreement, throughout the period of such continued operation, provided
      that any such continued operation shall in no way be construed as a
      renewal or other extension of this Agreement or the franchise granted
      pursuant to this Agreement, nor as a limitation on the remedies, if any,
      available to the City as a result of such continued operation after the
      Term, including, but not limited to, damages and restitution.

                  (b) In the event this Agreement terminates for any reason
      whatsoever and the Company fails to cease providing Service over the
      System, the City, in addition to all other remedies available to it under
      this Agreement or by law, shall be entitled to receive all payments it is
      entitled to receive under this Agreement including, but not limited to,
      the compensation set forth in Section 7.

                     SECTION 8 -- OVERSIGHT AND REGULATION

      8.1 Protection from Disclosure

            To the extent permissible under applicable law, the City shall
protect from disclosure any confidential, proprietary information submitted to
the City under this Agreement or made available to the City pursuant to Sections
8.5, 8.7.1 and 8.7.2, provided that the Company notifies the City of, and
clearly labels, the information which the Company deems to be confidential,
proprietary information. Such notification and labeling shall be the sole
responsibility of the Company.

      8.2 Oversight

            The City shall have the right to oversee, regulate and inspect
periodically the construction, maintenance, operation and upgrade of the System,
and any part thereof, in accordance with the provisions of this Agreement and
applicable law. The Company shall establish and maintain managerial and
operational records, standards, procedures and controls to enable the Company to
prove, in reasonable detail, to the satisfaction of the City at all times
throughout the Term, that the Company is in compliance with this Agreement. The
Company shall retain such records for not less than six (6) years following
their creation, and for such additional period as DoITT may direct.

      8.3 Notification to City

                  (a) The Company shall, upon the request of the Commissioner,
      but no more frequently than once a year, provide DoITT with a report
      describing the Services offered and classes of customers served by the
      Company during the previous twelve months. Further, such report shall
      describe the Company's plans for the coming twelve months with regard to
      new Services that the Company reasonably anticipates might be

                                      -22-
<PAGE>

      offered or new classes of customers that the Company reasonably
      anticipates might be served. Notwithstanding the requirements of this
      Section 8.3(a), the Company shall provide to the City, upon the City's
      request, any additional information that the City reasonably deems
      necessary during the Term.

                  (b) The Company shall also, on an annual basis, provide DoITT
      with a report describing any construction or installation of cable, wire,
      Fiber or other transmission medium that may be used in lieu of cable, wire
      or Fiber for the same purposes, or related equipment and facilities, in
      any areas outside of the Initial Backbone, that has occurred during the
      previous twelve months. Such report shall also describe the Company's
      reasonably anticipated plans for such construction and installation for
      the coming twelve months. Notwithstanding the requirements of this Section
      8.3(b), the Company shall provide to the City, upon the City's request,
      any additional information that the City reasonably deems necessary during
      the Term. It is not anticipated that confidential information will be
      required under this Section 8.3(b).

      8.4 Regulation by City

            To the full extent permitted by applicable law either now or in the
future, the City reserves the right to adopt or issue such rules, regulations,
orders, or other directives governing telecommunications that are consistent
with the terms of this Agreement and that it finds necessary or appropriate in
the lawful exercise of its police powers, and the Company expressly agrees to
comply with all such lawful rules, regulations, orders, or other directives.

      8.5 Reports

            8.5.1 Status Reports

                  The Company shall submit to DoITT reports describing, in
detail, the status of the construction of the Initial Backbone every six (6)
months from the Effective Date until its substantial completion. The Company
shall, upon substantial completion of the Initial Backbone, notify the
Commissioner in writing.

            8.5.2 Financial Reports

                  The Company shall submit to the Comptroller and DoITT not
later than three (3) months after the end of each annual fiscal period, a copy
of the Company's annual financial statements for such period which statements
shall be signed by the Chief Financial Officer of the Company, provided,
however, that the Comptroller may also require such statements to be audited and
certified by an independent certified public accountant in accordance with
generally accepted accounting principles. Such statements shall be accurate and
complete. The Company shall be permitted to provide consolidated financial
statements in satisfaction of this Section 8.5.2.

                                      -23-

<PAGE>

            8.5.3 Ownership Reports

                  The Company shall promptly report to the City any change in
ownership of the Company which is inconsistent with the description of
ownership set forth in Appendix G hereof.

            8.5.4 Additional Reports

                  The Company shall submit to DoITT, upon the request of the
Commissioner, but no more frequently than once a year, a report describing
the Company's compliance with its obligations under Sections 6.2 and 6.3
hereof. Such report shall be accurate and complete.

            8.5.5 Additional Information and Reports

                  Upon the request of the Commissioner, the Company shall
promptly submit to DoITT any information or report reasonably related to the
Company's obligations under this Agree, its business and operations, or those
of any Affiliated Person, with respect to the System or its operation, or any
Service distributed over the System, in such form and containing such
information as the Commissioner shall specify. such information or report
shall be accurate and complete.

      8.6   Additional Filings

            The Company shall provide upon the request of the
Commissioner, but no more frequently than once a year, to DoITT a list of any
and all material communications, public reports, petitions or other filings,
either received from or submitted to any municipal, county, state or federal
agency or official (and any response thereto submitted by or received by the
Company), which materially affects the operation of the System or any Service
or the Company's representations and warranties set forth herein, but not
including tax returns or other filings which are confidential. Upon the
request of DoITT, the Company shall promptly, but in no case later than ten
(10) business days following the request, deliver to DoITT a complete copy of
any item on said list.

      8.7 Books and Records/Audit

            8.7.1 Books and Records

                  Throughout the Term, the Company shall maintain complete
and accurate books of account and records of the business, ownership, and
operations of the Company with respect to the System in a manner that allows
the City at all times to determine whether the Company is in compliance with
the Agreement. Should the City reasonably determine that the records are not
being maintained in such a manner, the Company shall alter the manner in
which the books and/or records are maintained so that the Company comes into
compliance with this Section. All financial books and records which are
maintained in accordance with the regulations of the PSC and generally
accepted accounting principles shall be deemed to be acceptable under this
Section. The Company shall also maintain and provide such additional

                                      -24-
<PAGE>

books and records as the Comptroller or the Commissioner deem reasonably
necessary to ensure proper accounting of all payments due the City.

            8.7.2 Right of Inspection

                  The Commissioner and the Comptroller, or their designated
representatives, shall had the right to inspect, examine or audit during
normal business hours and upon reasonable notice to the Company under the
circumstances, all documents, orecords or other information which pertain to
the Company or any Affiliated Person with respect to the System, its
operation, its employment and purchasing practices, Services distributed over
the System, and with respect to the Company's obligations pursuant to this
Agreement. All such documents shall be made available within New York City or
in such other place that the City may agree upon in writing in order to
facilitate said inspection, examination, or audit, provided, however, that is
such documents are located outside of the City, then, upon notice to the
Company, the Company shall pay the reasonable expenses incurred by the
Commissioner, the Comptroller or their designated representatives in
travelling to such location. All of such documents shall be retained by the
Company for a minimum of six (6) years following termination of this
Agreement. Access by the City to any of the documents covered by this Section
8.7.2 shall not be denied by the Company on grounds that such documents are
alleged by the Company to contain confidential, proprietary or privileged
information, provided that this requirement shall not be deemed to constitute
a waiver of the Company's right to assert that confidential, proprietary or
privileged information contained in such documents should not be disclosed,
subject to Section 8.1 hereof. In order to determine the validity of such
assertion and withholding by the Company, the City agrees to review the
alleged proprietary information, and/or a log of the documents believed by
the Company to be privileged reflecting sufficient information to establish
the privilege claimed, at the Company's premises and, in connection with such
review, to limit access to the alleged proprietary information to those
individuals who require the information in the exercise of the City's rights
under this Agreement. If the Corporation Counsel of the City concurs with the
Company's assertion regarding the proprietary nature of such information, the
City will hold such information in confidence to the extent authorized by and
in accordance with applicable law and will not remove from the Company's
premises the proprietary portion of any document or other intangible thing
that contains such proprietary information. If the Corporation counsel of the
City concurs with the Company's assertion regarding the privileged nature of
such information, then the Company will not be required to disclose such
information. If the Corporation Counsel of the City does not concur with such
assertions, then the Company shall promptly provide such documents, including
the alleged proprietary or privileged portion thereof, to the City, provided
that the Company shall not be required to provide the proprietary or
privileged portion thereof during the pendency of any court challenge to such
provision.

      8.8 Compliance with "Investigations Clause"

            The Company agrees to comply in all respects with the City's
"Investigations Clause," a copy of which is attached at Appendix F hereto.

                                      -25-

<PAGE>

        SECTION 9 - RESTRICTIONS AGAINST ASSIGNMENT AND OTHER TRANSFERS

      9.1   Transfer of Interest

            Except as provided in Section 96 hereof and Appendix G hereto,
and excepting conveyances and leases of real or personal property in the
ordinary course of the operation of the System (but not excepting leases
which by their size or nature are the functional equivalent of transfers of
the System), neither the franchise granted herein nor any rights or
obligations of the Company in the System or pursuant to this Agreement shall
be encumbered, assigned, sold, transferred, pledged, leased, sublet, or
mortgaged in any manner, in whole or in part, to any Person, nor shall title
therein, either legal or equitable, or any right or interest therein, pass to
or vest in any Person, either by act of the Company, by act of any Person
holding Control of or any interest in the Company or the System or the
franchise granted herein, by operation of law, or otherwise, without the
prior written consent of the City pursuant to the procedures set forth in
this Section 9, provided that the City shall consider any such action in
accordance with its usual procedural rules.

      9.2   Transfer of Control or Stock

            Notwithstanding any other provision of this Agreement, except as
provided in Section 9.6 hereof or as set forth in on Appendix G, no change in
Control of the Company, the System or the franchise granted herein shall
occur after the Effective Date, by act of the Company, by act of any Person
holding Control of the Company, the System or the franchise granted herein,
by operation of law, or otherwise, without the prior written consent of the
City granted pursuant to the procedures set forth in this Section 9. The
requirements of Section 9.3 hereof shall also apply whenever any change is
proposed of ten percent (10%) or more of the ownership or Control of the
Company, the System, the franchise granted herein or of any Person holding
Control of the Company or in the System or in the franchise (but nothing
herein shall be construed as suggesting that a proposed change of less than
ten percent (10%) does not require consent of the City (acting pursuant to
the procedures set forth in this Section 9) if it would in face result in a
change in Control of the Company, the system or the franchise granted
herein), and any other event which could result in a change in ownership or
Control of the Company, regardless of the manner in which such ownership or
Control is evidenced (e.g., stock, bonds, debt instruments or other indicia
of ownership or Control).

      9.3   Petition

            The Company shall promptly notify the Commissioner of any
proposed action requiring the consent of the City pursuant to Sections 9.1 or
9.2 hereof or to which this Section 9.3 applies by submitting to the
Commissioner, with a copy of the Corporation Counsel, a petition requesting
the submission by the Commissioner of such petition to the FCRC and approval
thereof by the FCRC or requesting a determination that no such submission and
approval is required and its argument why such submission and approval is not
required. Each petition shall fully describe the proposed action and shall be
accompanied by a justification for the action and, if applicable, the
Company's argument as to why such action would not involve a change in
Control of the Company, the System or the franchise, and such additional
supporting information as the Commissioner and/or the FCRC may reasonably
require in order to review

                                      -26-

<PAGE>

and evaluate the proposed action. The Commissioner shall expeditiously review
the petition and shall (a) notify the Company in writing if the Commissioner
determines that the submission by the Commissioner and the approval of the
FCRC is not required or (b) if the Commissioner determines that such
submission and approval is required, either (i) notify the Company that the
Commissioner does not approve the proposed action and therefore will not
submit the petition to the FCRC, or (ii) submit the petition to the FCRC for
its approval.

      9.4   Consideration of the Petition

            DoITT and the FCRC, as the case may be, may take such actions as
it deems appropriate in considering the petition and determining whether
consent is needed or should be granted. In considering the petition, DoITT
and the FCRC, as the case may be, may inquire into: (i) the qualifications of
each Person involved in the proposed action, (ii) all matters relevant to
whether the relevant Person(s) will adhere to all applicable provisions of
this Agreement, (iii) the effect of the proposed action on competition; and
(iv) all other matters it deems relevant in evaluating the petition,
including whether the Company executed this Agreement under a good faith
belief that it would itself carry out the obligations of the Company
hereunder. After receipt of a petition, the FCRC may, as it deems necessary
or appropriate, schedule a public hearing on the petition. Further DoITT and
the FCRC may review the Company's performance under the terms and conditions
of this Agreement. The Company shall provide all requested assistance to
DoITT and the FCRC in connection with any such inquiry and, as appropriate,
shall secure the cooperation and assistance of all Persons involved in said
action.

      9.5   Conditions

            As a condition to the granting of any consent required by this
Section 9, the Commissioner and/or the FCRC may: (i) upon a determination
that the Company did not execute this Agreement under a good faith belief
that it would itself carry out the obligations of the Company pursuant to
this Agreement, require the Company of any Affiliated Person to pay to the
City part or all of the profits earned or to be earned by such Person in
connection with, upon the completion of, or as a result of, any of the
actions described in Sections 9.1 or 9.2 hereof with respect to any of such
actions which occur within the four (4) years after the Effective Date; and
(ii) require that each Person involved in any action described in Sections
9.1 or 9.2 hereof shall execute an agreement, in a form and containing such
conditions as may be specified by the City, providing that such Person
assumes and agrees to be bound by all applicable provisions of this Agreement
and such other conditions which the City deems necessary or appropriate in
the circumstances. The execution of such agreement by such Person(s) shall in
no way relieve the Company or any other transferor involved in any action
described in Sections 9.1 or 9.2 hereof, of its obligations pursuant to this
Agreement.

      9.6   Permitted Encumbrances

            Nothing in this Section 9 shall be deemed to prohibit any
assignment, pledge, lease, sublease, mortgage, or other transfer of all or
any part of the System, or any right or interest therein, for financing or
refinancing purposes, provided that each such assignment, pledge, lease,
sublease, mortgage, or other transfer shall be subject to the rights of the
City pursuant to this Agreement and applicable law. The consent of the City
shall not be required

                                      -27-

<PAGE>

with respect to any transfer to, or taking of possession by, any banking or
lending institution which is s secured creditor of the Company or all or any
part of the System pursuant to the rights or such secured creditor under
Article 9 of the Uniform Commercial Code, as in effect in the State of New
York, and, to the extent that the collateral consists of real property, under
the New York Real Property Law; provided, further that, the City's rights are
in no way adversely affected or diminished.

      9.7   Consent Not a Waiver

            The grant or waiver of any one or more of such consents shall not
render unnecessary any subsequent consent, nor shall the grant of any such
consent constitute a waiver of any other rights of the City, as required in
this Section 9.

      9.8   Petitions From Persons Other Than the Company
            Seeking Control Over the Company

            Notwithstanding the foregoing, DoITT reserves the right, on a
case-by-case basis, to accept, hear and/or grant petitions for the transfer
of Control of the Company, the System or the franchise granted herein from
Persons seeking to obtain Control of the Company. Notwithstanding the
foregoing, the City shall provide the Company with reasonable notice of any
such petitions and the Company shall be afforded the opportunity to respond
to any such petitions before the City grants any approval with respect to
such petitions, including but not limited to, the hearing or granting of such
petitions. The City, its officers, employees, agents, attorneys, consultants
and independent contractors shall not be liable to the Company or any other
Person for exercising its rights herein. The Company shall be entitled to
rely upon publicly filed reports to which it has access in connection with
its determination of the applicability of this Section 9.8, except to the
extent the Company knows or has reason to believe that any such report is or
may be incorrect, or is aware of the information which is the subject of this
Section otherwise than as a result of publicly filed reports.

                    SECTION 10 - LIABILITY AND INSURANCE

      10.1  Liability and Indemnity

            10.1.1 Company

                   The Company shall be liable for, and the Company and each
Affiliated Person (not including a limited partner or an individual
shareholder) shall indemnify, defend and hold the City, its officers, agents,
servants, employees, attorneys, consultants and independent contractors (the
"Indemnitees") harmless from, any and all liabilities, suits, obligations,
fines, damages, penalties, claims, costs, charges and expenses (including,
without limitation, reasonable attorneys' fees and disbursements), that may
be imposed upon or incurred by or asserted against any of the Indemnitees
arising out of the construction, operation, maintenance, upgrade, repair or
removal of the System or otherwise arising out of or related to this
Agreement; provided, however, that the foregoing liability and indemnity
obligation of the Company pursuant to this Section 10.1 shall not apply to
any willful misconduct or gross negligence of the City, its officers,
employees, servants, agents, attorneys, consultants or independent
contractors.

                                      -28-

<PAGE>

Further, it is a condition of this Agreement that the City assumes no liability
for liabilities, suits, obligations, fines, damages, penalties, claims, costs,
charges and expenses (including, without limitation, reasonable attorneys' fees
and disbursements) to either Persons or property on account of the same, except
as expressly provided herein.

            10.1.2 No Liability for Public Work, etc.

                  None of the City, its officers, agents, servants, employees,
attorneys, consultants or independent contractors shall have any liability to
the Company for any damage as a result of or in connection with the protection,
breaking through, movement, removal, alteration or relocation of any part of the
System by or on behalf of the Company or the City in connection with any
emergency, public work, public improvement, alteration of any municipal
structure, any change in the grade or line of any Inalienable Property of the
City, or the elimination, discontinuation, closing or demapping of any
Inalienable Property of the City, as provided in Sections 2.4.5 and 5.4 hereof.
When reasonably possible, the Company shall be consulted prior to any such
activity and shall be given the opportunity to perform such work itself, but the
City shall have no liability to the Company in the event it does not so consult
the Company. All costs to repair or replace the System, or parts thereof,
damaged or removed as a result of such activity shall be borne by the Company;
provided, however, that the foregoing obligations of the Company pursuant to
this Section 10.1.2 shall not apply to any willful misconduct or gross
negligence of the City, its officers, employees, servants, agents, attorneys,
consultants or independent contractors.

            10.1.3 No Liability for Damages

                  None of the City, its officers, agents, servants, employees,
attorneys, consultants and independent contractors shall have any liability to
the Company for any special, incidental, consequential, punitive, or other
damages as a result of the proper and lawful exercise of any right of the City
pursuant to this Agreement or applicable law, including, without limitation, the
rights of the City to terminate, amend, or otherwise modify all or any part of
this Agreement or the franchise granted herein; provided, however, that the
foregoing limitation on liability pursuant to this Section 10.1.3 shall not
apply to any willful misconduct or gross negligence of the City, its officers,
employees, servants, agents, attorneys, consultants or independent contractors.

            10.1.4 Defense of Claim, etc.

                  If any claim, action or proceeding is made or brought against
any of the Indemnitees by reason of any event to which reference is made in
Section 10.1.1 hereof, then upon demand by the City, the Company shall either
resist, defend or satisfy such claim, action or proceeding in such Indemnitee's
name, by the attorneys for, or approved by, the Company's insurance carrier (if
such claim, action or proceeding is covered by insurance) or by the Company's
attorneys. The foregoing notwithstanding, upon a showing that the Indemnitee
reasonably requires additional representation, such Indemnitee may engage its
own attorneys to defend such Indemnitee, or to assist such Indemnitee in such
Indemnitee's defense of such claim, action or proceeding, as the case may be,
and the Company shall pay the reasonable fees and disbursements of such
attorneys of such Indemnitee.

                                      -29-
<PAGE>

      1.2 Insurance

            10.2.1 Specifications

                  Prior to the execution of this Agreement, the Company has, at
its own cost and expense, obtained and furnished to DoITT, with a copy to the
Comptroller, a liability or umbrella insurance policy taking effect no later
than the Original Agreement Date, insuring the Company and the City, its
officers, agents, servants, employees, attorneys, consultants and independent
contractors against each and every form of liability referred to in Section 10.1
herein, in the minimum combined amount of fifty million dollars ($50,000,000),
covering bodily injury, including death, personal injury and property damage.
Such policy or policies have been issued by companies duly licensed to do
business in the State of New York and acceptable to the Comptroller, carrying a
rating by Best's of not less than A. The foregoing minimum coverage shall not
prohibit the Company from obtaining a liability insurance policy or policies
with coverage in excess of such minimum, provided that the City shall be named
as an additional insured to the full extent of any limitation contained in any
such policy or policies obtained by the Company. The Company shall be permitted
to provide evidence of a blanket policy in satisfaction of this Section 10.2.1.

            10.2.2 Maintenance

                  (a) The Company shall continuously maintain one or more
      liability insurance policies meeting the requirements in Section 10.2.1
      hereof throughout the Term and thereafter until completion of removal of
      the System over, under or on the Inalienable Property of the City to the
      extent such removal is required pursuant to this Agreement.

                  (b) Each such liability insurance policy shall contain the
      following endorsement: "It is hereby understood and agreed that this
      policy may not be canceled nor the intention not to renew be stated until
      ninety (90) days after receipt by the City, by registered mail, of a
      written notice of such intent to cancel or not to renew." Within sixty
      (60) days after receipt by the City of any said notice, and in no event
      later than thirty (30) days prior to any said cancellation, the Company
      shall obtain and furnish to DoITT, with a copy to the Comptroller,
      replacement insurance policies in a form reasonably acceptable to DoITT
      and the Comptroller together with evidence demonstrating that the premiums
      for such insurance have been paid.

            10.2.3 Adjusted Insurance Coverage

                  The Company agrees to adjust the minimum coverage of the
liability insurance policy or policies required by Section 10.2.1 within three
(3) months of notice from the City that the City has reasonably determined that
additional amounts or types of insurance are being commonly carried with respect
to systems of a size and nature similar to the System or other circumstances
have arisen which make it reasonably prudent to obtain such additional amounts
or types of insurance.

                                      -30-
<PAGE>

            10.2.4 Liability Not Limited

                  The liability of the Company and any Affiliated Person (not
including a limited partner or an individual shareholder) to the City or any
Person for any of the matters which are the subject of the liability insurance
policy or policies required by this Section 10.2 shall not be limited by said
insurance policy or policies nor by the recovery of any amounts thereunder;
provided, however, that the City shall in no case be entitled to duplicative
recoveries from different sources.

                   SECTION 11 - SPECIFIC RIGHTS AND REMEDIES

      11.1 Not Exclusive

            The Company agrees that the City shall have the specific rights and
remedies set forth in this Section 11. These rights and remedies are in addition
to and cumulative of any and all other rights or remedies, existing or implied,
now or hereafter available to the City at law or in equity in order to enforce
the provisions of this Agreement. Such rights and remedies shall not be
exclusive, but each and every right and remedy specifically provided or
otherwise existing or given may be exercised from time to time and as often and
in such order as may be deemed expedient by the City, except as provided herein.
The exercise of one or more rights or remedies shall not be deemed a waiver of
the right to exercise at the same time or thereafter any other right or remedy
nor shall any such delay or omission be construed to be a waiver of or
acquiescence to any default. The exercise of any such right or remedy by the
City shall not release the Company from its obligations or any liability under
this Agreement, provided, however, that the City shall in no case be entitled to
duplicate recoveries from different sources.

      11.2 Default

            11.2.1 Events of Default

                   In addition to any other Event of Default specified herein,
any of the following shall constitute an Event of Default:

                   (a) any breach of a provision of the Agreement requiring the
      Company (i) to replenish the Performance Bond/Security Fund (Section
      5.8.6); (ii) to maintain the Performance Bond/Security Fund (Section 5.8);
      (iii) to make any payments to the City; (iv) to maintain a liability
      insurance policy (Section 10.2); or (v) to provide or furnish information
      to the City, that is not cured within thirty (30) days after notice
      pursuant to Section 11.2.2;

                   (b) any substantial breach of a material provision of this
      Agreement by the Company that is not cured within thirty (30) days after
      notice pursuant to Section 11.2.2; or

                   (c) any persistent failure by the Company to comply with any
      of the provisions, terms or conditions of this Agreement or with any
      rules, regulations, orders or other directives of the City after having
      received notice of a failure to comply.

                                      -31-

<PAGE>

            11.2.3 Cure Procedures

                   (a) The Commissioner shall notify the Company, in writing,
of any breach under this Agreement, in accordance with Section 13.5 hereof.
The notice shall specify the alleged breach(es) with reasonable
particularity. The Company shall either (i) within the number of days set
forth in the applicable paragraph of Section 11.2.1 hereof, or such longer
period of time as the Commissioner may specify in such notice, cure such
alleged breach(es); or (ii) in a written response submitted to the
Commissioner within fifteen (15) days after the notice of breach, present
facts and arguments in refutation or excuse of such alleged failure. The
submission of such a response shall toll the running of the applicable cure
period as provided in Section 11.2.1 hereof. Notwithstanding the preceding,
no Event of Default shall exist if a breach is curable but work to be
performed, acts to be done, or conditions to be removed which cannot, by
their nature, reasonably be performed, done or removed within the cure period
provided, so long as the Company shall have commenced curing the same within
the cure period provided and shall diligently and continuously prosecute the
same promptly to completion.

                   (b) If the Company fails to cure the breach within the
applicable cure period, and fails to submit a response to the Commissioner
pursuant to subparagraph (a) hereof within the period provided herein for
submitting such response, an Event of Default will be deemed to have occurred.

                   (c) If, after the Company makes a response to the
Commissioner, the Commissioner determines, in his or her reasonable
discretion, that a breach under this Agreement has occurred, the Company
shall cure such breach within the balance of the time period to cure that
remained when the submission was made. If the Company is not able to cure
within the remaining time, the breach will be deemed to be an Event of
Default provided, however, that no Event of Default shall exist if a breach
is curable but work to be performed, acts to be done, or conditions to be
removed which cannot, by their nature, reasonably be performed, done or
removed within the cure period remaining, so long as the Company shall have
commenced curing the same within the cure period provided and shall
diligently and continuously prosecute the same promptly to completion.

                   (d) If, as a result of a failure or alleged failure to
comply with a material provision of this Agreement, the Company is unable to
comply with any other material provision(s) which necessarily and directly
arise(s) out of said failure or alleged failure as delineated in said
subsections, such inability to comply with such other provision(s) shall not
be deemed to be an independent failure to comply with a material provision of
this Agreement.

            11.2.3 Remedies of the City

                   (a) Upon an Event of Default, DoITT may:

                        (i) cause a withdrawal from the Performance Bond/
            Security Fund for any specified amount due the City under this
            Agreement;

                                      -32-

<PAGE>

                        (ii) assess money damages from the Company as
            compensation for such Event of Default;

                        (iii) revoke the franchise granted pursuant to this
            Agreement by termination of this Agreement;

                        (iv) accelerate the expiration of the Term by decreasing
            the term of the franchise provided in Section 2.1 hereof, provided
            that the remaining term of the franchise as accelerated pursuant to
            this Section 11.2.3(a)(iv) shall not be less than twelve (12)
            months;

                        (v) restrain by injunction, the default or reasonably
            anticipated default by the Company of any provision of this
            Agreement; and

                        (vi) invoke any other available remedy that would be
            permitted by law.

                  (b) DoITT shall give the Company notice in writing when it
      determines to pursue one or more remedies, but nothing herein shall
      prevent DoITT from electing more than one remedy, simultaneously or
      consecutively, for any default, provided, however, that the City shall in
      no case be entitled to duplicate recoveries from different sources.

      11.3 Termination

            11.3.1 Termination Events

                  (a) The occurrence of any of the following shall result in
      termination of the Agreement:

                        (i) the occurrence of any event relating to the
            financial status of the Company which may reasonably lead to the
            foreclosure or other judicial or nonjudicial sale of all or any
            material part of the System, and the Company fails to demonstrate to
            the reasonable satisfaction of the Commissioner within thirty (30)
            days after notice that such event will not lead to such foreclosure
            or other judicial or nonjudicial sale;

                        (ii) the condemnation by public authority, other than
            the City or sale or dedication under threat or in lieu of
            condemnation, of all or substantially all of the System, the effect
            of which would materially frustrate or impede the ability of the
            Company to carry out its obligations and the purposes this Agreement
            and the Company fails to demonstrate to the reasonable satisfaction
            of the Commissioner, within thirty (30) days after notice that such
            condemnation, sale or dedication would not materially frustrate or
            impede such ability of the Company;

                        (iii) except as otherwise provided in Section 9.6, if:
            (A) the Company shall make an assignment of the Company or
            substantially all of the

                                      -33-
<PAGE>

            System for the benefit of creditors, shall become and be adjudicated
            insolvent, shall petition or apply to any tribunal for, or consent
            to, the appointment of , or taking possession by, a receiver,
            custodian, liquidator or trustee or similar official pursuant to
            state or local laws, ordinances or regulations of or for it or any
            substantial part of its property or assets, including all or any
            part of the System; (B) a writ or warranty of attachment, execution,
            distraint, levy, possession or any similar process shall be issued
            by any tribunal against all or any material part of the Company's
            property or assets; (C) any creditor of the Company petitions or
            applies to any tribunal for the appointment of, or taking possession
            by, a trustee, receiver, custodian, liquidator or similar official
            for the Company or of any material parts of the property or assets
            of the Company under the law of any jurisdiction, whether now or
            hereinafter in effect, and a final order, judgment or decree is
            entered appointing any such trustee, receiver, custodian, liquidator
            or similar official, or approving the petition in any such
            proceeding or (D) any final order, judgment or decree is entered in
            any proceedings against the Company decreeing the voluntary or
            involuntary dissolution of the Company; or

                        (iv) if there shall occur any denial, forfeiture or
            revocation by any federal, state or local governmental authority
            having regulatory jurisdiction over the Company of an authorization
            required by law or the expiration without renewal of any such
            authorization, and such events, either individually or in the
            aggregate, materially jeopardize the System or its operation, and
            the Company fails to take steps to obtain or restore such
            authorization within thirty (30) days after notice.

                  (b) In addition, an Event of Default under Section 11.2 herein
      may result in termination of the Agreement.

            11.3.2 Rights Upon Termination

                  In the event of any termination of this Agreement, whether
pursuant to Section 11.3.1 hereof, by the expiration of the Term or by
revocation of the franchise by DoITT, the Company, at the City's election, shall
(a) sell to the City or to the City's designee the portions of the System on,
over or under the Inalienable Property of the City and all equipment necessary
for the functioning of such portions of the System; and/or (b) remove the
System, of portions of the System, installed on, over or under the Inalienable
Property of the City at the Company's own cost and expense, pursuant to Section
11.4 hereof.

            11.3.3 Price

                  (a) The price to be paid to the Company upon an acquisition
      pursuant to Section 11.3.2 herein shall be fair value (or, in case of
      termination by revocation, an equitable price, determined with due regard
      to the inquiry to the City and its residents), with no value allocable to
      the franchise itself, which price shall be the fair value as provided in
      Section 33(h)(S) of the City Charter, as may be amended, or under any
      successor provision. Subject to the limitations found in the next
      sentence, to the extent the City effects an acquisition pursuant to
      Section 11.3.2 herein and subsequently sell

                                      -34-
<PAGE>

      that portion of the System acquired to a third party, and the amount
      received by the City from such sale exceeds the price paid by the City to
      the Company pursuant to this Section 11.3.3, the City shall pay such
      excess amount to the Company after deducting all reasonable expenses
      incurred by the City in connection with such acquisition and sale. The
      preceding sentence shall apply only in cases where the Agreement has
      terminated by reason of the expiration of the full Term or by reason of
      the occurrence of an event in Section 11.3.1 (a) hereof, and shall not
      apply in any case where the Agreement has been terminated for cause. In
      cases where the Agreement has been terminated for cause and the City
      effects an acquisition or transfer of the System for any reason, and the
      party acquiring the System acquires it directly from the Company, then The
      City shall be entitled to receive from such party any amount in excess of
      the price which the City could have received if it had purchase the System
      from the Company and subsequently sold the System to such third party.

                  (b) The date of valuation for purposes of Section 11.3.2
      hereof shall be the date of termination of the Agreement. For the purpose
      of determining such valuation, the parties shall select a mutually
      agreeable independent appraiser to compute the purchase price in
      accordance with industry practice and the aforementioned standards. If
      they cannot agree on an appraiser in ten (10) days, the parties will seek
      an appraiser from the American Arbitration Association. The appraiser
      shall be instructed to make the appraisal as expeditiously as possible,
      but in no more than sixty (60) days and shall submit to both parties a
      written appraisal. The appraiser shall be afforded access to the Company's
      books and records, as necessary to make the appraisal. Not withstanding
      the provisions of Section 7.2.2 hereof, the parties shall share equally
      the costs and expenses of the appraiser.

                  (c) The City will notify the company, within thirty (30) days
      after receipt of the appraisal, of its election of rights pursuant to
      Section 11.3.2 hereof. If it elects to make the purchase permitted under
      Section 11.3.2 hereof. If it elects make the purchase permitted under
      Section 11.3.2 hereof, it will purchase the same at closing to occur
      within a reasonable time after its election.

                  (d) The Company agrees, at the request of the City, (i) to
      operate the System on behalf of the City pursuant to the provisions of
      this Agreement and such additional terms and conditions as are equitable
      to the City and the Company for a period of up to four (4) months after
      the termination of this Agreement, until the City either elects not to
      purchase any portion of the System, or closes on such a purchase, or (ii)
      to cease all construction and operational activities in a prompt and
      workmanlike manner.

            11.3.4 Company's Obligations

                  In the event of any acquisition of the System by the City or
the City's designee pursuant to Section 11.3.2 hereof, the Company shall:

                  (a) cooperate with the City to effectuate an orderly transfer
      of all records and information concerning the System to the City;

                                      -35-
<PAGE>

                  (b) promptly execute all appropriate documents to transfer to
      the City subject to any liabilities, title to the System as well as all
      contracts, leases, licenses, permits, rights-of-way, and any other rights,
      contracts or understanding necessary to maintain and operate the System,
      as appropriate; provided, that such transfers shall be made subject to the
      rights, under Article 9 of the Uniform Commercial code as in effect in the
      State of New York and, to the extent that any collateral consists of real
      property under the New York Real Property Law, of banking or any other
      lending institutions which are secured creditors or mortgagees of the
      Company at the time of such transfers; and provided, that, with respect to
      such creditors and mortgagees, the City shall have no obligation following
      said transfers to pay, pledge, or otherwise commit in any way any general
      or any other revenues or funds of the City, other than the gross operating
      revenues received by the City from its operation of the System, in order
      to repay any amounts outstanding on any debts secured by the System which
      remain owing to such creditors or mortgagees; and provided, finally, that
      the total of such payments by the City to such creditors and mortgages,
      from the gross operating revenues received by the City from its operation
      of the System, shall in no event exceed the lesser of: (i) the fair market
      value of the System on the date of the transfer of title to the City or
      (ii) the outstanding debt owed to such creditors and mortgagees on said
      date. Nothing in this Section 11.3. shall be construed to limit the rights
      of any such secured creditors to exercise it or their rights as secured
      creditors or mortgagees at any time prior to the payment of all amounts
      due pursuant to the applicable debt instruments; and

                  (c) promptly supply the Commissioner with all necessary
      records (i) to reflect the City's ownership of the System; and (ii) to
      operate and maintain the System including, without limitation, all
      Customer records and plant and equipment layout documents.

      11.4 Removal

            11.4.1 Discretion of DoITT

                  Upon any termination of this agreement, DoITT, in its sole
discretion may, but shall not be obligated to, direct the Company to remove, at
the Company's sole cost and expense, all, or any portion designated by DoITT, of
the System installed by the Company from the Inalienable Property of the City in
accordance with all applicable requirements of the City and subject to the
following:

                  (a) this provision shall not apply to buried portions of the
      System which, in the opinion of DoITT, cannot be removed;

                  (b) in removing the System, or part thereof, the Company shall
      refill and compact, at its own cost and expense, any excavation that shall
      be made by it and shall leave, in all material aspects, all Inalienable
      Property and other property in as good condition as that prevailing prior
      to the Company's removal of the System from Inalienable Property of the
      City and without affecting, altering or disturbing in any way any
      electric, telephone or other cables, wires, structures or attachments;

                                      -36-
<PAGE>

                  (c) the City shall have the right to inspect and approve the
      condition of such Inalienable Property after removal and, to the extent
      that the City determines that said Inalienable Property and other property
      have not been left in materially as good condition, as that prevailing
      prior to the Company's removal of the System, the Company shall be liable
      to the City for the cost or restoring the Inalienable Property and other
      property to said condition;

                  (d) the Performance Bond/Security Fund, liability insurance
      and indemnity provisions of this Agreement shall remain in full force and
      effect during the entire period of removal and associated repair of all
      Inalienable Property of the City, and for not less that one hundred twenty
      (120) days thereafter; and

                  (e) removal shall be commenced within thirty (30) days of the
      removal order by DoITT and shall be substantially completed within twelve
      (12) months thereafter including all reasonably associated repair of the
      Inalienable Property of the City.

            11.4.2 Failure to Commence Removal

                  If, in the reasonable judgment of the Commissioner, the
Company fails to commence removal of the System as designated by DoITT, within
thirty (30) days after DoITT's removal order, or if the Company fails to
substantially complete such removal, including all associated repair of the
Inalienable Property of the City, within twelve (12) months thereafter, then, to
the extent not inconsistent with applicable law, the City shall have the right
to:

                  (a) declare that all rights, title and interest to the System
      belong to the City with all rights of ownership including, but not limited
      to, the right to connect and use the System or to effect a transfer of all
      right, title and interest in the System to another Person for operation;
      or

                  (b) authorize removal of the System installed by the Company
      on, over or under the Inalienable Property of the City at the Company's
      cost and expense, by another Person; and

                  (c) to the extent consistent with applicable law, and portion
      of the Company's System on, over or under the Inalienable Property of the
      City designated by DoITT for removal and not timely removed by the Company
      shall belong to and become the property of the City without payment to the
      Company notwithstanding the provisions of Section 11.3.2 hereof, and the
      Company shall execute and deliver such documents, the Commissioner shall
      request, in form and substance acceptable to the Commissioner, to evidence
      such ownership by the City.

            11.4.3 No Condemnation

                  None of the declaration, connection, use, transfer or other
actions by the City or the Commissioner under Section 11.4.2 shall constitute a
condemnation by the City or a sale or dedication under threat or in lieu of
condemnation.

                                      -37-
<PAGE>

      11.5 Return of Performance Bond/Security Fund

            Upon the later of the date one hundred and twenty (12)) days after
the termination of this Agreement for any reason or the date of the completion
of removal of the System from and associated repair of the Inalienable Property
of the City pursuant to Section 11.4.1 hereof, the Company shall be entitled to
the return of the Performance Bond/Security Fund deposited pursuant to Section
5.8 hereof, or such portion thereof as remains on deposit with the Comptroller
at said termination, provided that all offsets necessary (a) to compensate the
City pursuant to Section 5.8.2 and/or 5.8.3 hereof, (b) to cover any costs, loss
or damage incurred by the City as a result of any Event of Default, in the event
of termination of this Agreement by the City pursuant to Section 11.3 hereof,
and (c) to reimburse the City for the cost of removal of the System from the
Inalienable Property of the City pursuant to Section 11.4.2 hereof have been
taken by the City.

      11.6 Other Provisions

            The City and the Company shall negotiate in good faith all other
terms and conditions of any such acquisition or transfer, except that the
Company hereby waives its rights, if any to relocation costs arising out of the
termination of this Agreement pursuant to this Section 11 that may be provided
by law and except that, in the event of any acquisition of the System by the
City: (i) the City shall not be required to assume any of the obligations of any
collective bargaining agreements or any other employment contracts held by the
Company or any other obligation of the Company or its officers, employees, or
agents including, without limitation, any pension or other retirement, or any
insurance obligations; and (ii) the City may lease, sell, operate, or otherwise
dispose of all or any part of the System in any manner.

                          SECTION 12-SUBSEQUENT ACTION

      12.1 Compensation

            In the event that, after the Effective Date any court, agency,
commission, legislative body, or other authority of competent jurisdiction takes
any action or enters any judgment which has a materially adverse effect, with
respect to the City or the Company, on the compensation or other payments to be
made by the Company pursuant to Section 7 of this Agreement, then the Company
and DoITT shall enter into negotiations to amend this Agreement in a manner not
inconsistent with any such action or judgment so as to establish a fair and
equitable relationship between the parties. In the event that either party fails
to negotiate in good faith to produce an agreement which is reasonably
acceptable to both parties within a reasonable period, then either party shall
have the right, by notice to the other, to accelerate the term of this Agreement
and the franchise granted hereunder such that the term and the franchise shall
terminate on the date which is one half of the number of days between the date
of such notice and the fifteenth anniversary of the Original Agreement Date, but
in no event shall the City be permitted to reduce the Term of this franchise by
virtue of this Section 12.1 such that the Term of this franchise is less than 10
years.

                                      -38-
<PAGE>

      12.2 Procedure for subsequent Invalidity

            12.2.1 Declaration of Invalidity or Injunction

                  Except as provided in Section 12.1 hereof, in the event that,
after the Effective Date, any court, agency, commission, legislative body, or
other authority of competent jurisdiction:

                  (a) declares this Agreement invalid, in whole or in part, or

                  (b) requires the City or the Company either to: (i) perform
      any act which is inconsistent with any provision of this Agreement or (ii)
      cease performing any act required by any provision of this Agreement, then
      the Company or the City, as the case may be, shall promptly notify the
      other party in writing of such fact.

            1.1.2 Continued Compliance

                  After the occurrence of the events described in Section 12.2.1
hereof, the Company and the City shall continue to comply with all provisions of
this Agreement, including the affected provision, until the validity of the
declaration or requirements has been finally adjudicated or a court orders the
Company or the City to comply with such declaration or order, provided that
either party may comply with any court order which is not stayed during the
pendency of any appeal leading to said final adjudication.

            12.2.3 Negotiations to Amend Agreement

                  Except as provided in Section 12.1 hereof, to the extent that
any statute, rule, regulation, ordinance or any other law is enacted, adopted,
repealed, amended, modified, changed or interpreted in any way during the term
of this Agreement so as to (a) declare the Agreement invalid, in whole or in
part, or (b) require the Company or City either to: (i) perform any act which is
inconsistent with any provision of this Agreement, or (ii) cease performing any
act required by any provision of this Agreement, the Company and City shall
enter into good faith negotiations so as to modify this Agreement and /or
regulate the System, as applicable, to reflect such enactment, adoption, repeal,
amendment, modification, change or interpretation and the Company agrees to
comply with any such modifications or regulations arising out of such
negotiations. In the event that either party fails to negotiate in good faith to
produce an agreement which is reasonably acceptable to both parties within a
reasonable period, then either party shall have the right, by notice to the
other, to accelerate the term of this Agreement and the franchise granted
hereunder such that the term and the franchise shall terminate on the date which
is one half of the number of days between the date of such notice and the
fifteenth anniversary of the Original Agreement Date but in no event shall the
City be permitted to reduce the Term of this franchise by virtue of this Section
12.2.3 such that the Term of this franchise is less than 10 years.

                                      -39-
<PAGE>

                            SECTION 13-MISCELLANEOUS

      13.1 Appendices

            The Appendices to this Agreement, attached hereto, and all portions
thereof and exhibits thereto, are, except as otherwise specified in said
appendices, incorporated herein by reference and expressly made a part of this
Agreement. The procedures for approval of any subsequent amendment or
modification to said Appendices shall be the same as those applicable to any
amendment or modification hereof.

      13.2 Action Taken by City

            Any action to be taken by DoITT pursuant to this Agreement shall be
taken in accordance with the applicable provisions of the City Charter as said
Charter may be amended or modified throughout the Term. Whenever, pursuant to
the provisions of this Agreement, the City, the Company, or any other Person is
required or permitted to take any action, including, without limitation, the
making of any request or the granting of any consent, approval, or
authorization, the propriety of said action shall be measured against the
standard of reasonableness such that each such action shall be undertaken in a
reasonable manner, unless this Agreement authorizes the City, the Company, or
other Person to take such action in its sole discretion.

      13.3 Entire Agreement

            This Agreement, including all Appendices hereto, embodies the entire
understanding and agreement of the City and the Company with respect to the
subject matter hereof and merges and supersedes all prior representations,
agreements and understandings, whether oral or written, between the City and the
Company with respect to the subject matter hereof, including, without
limitation, all prior drafts of this Agreement and any Appendix to this
Agreement and any and all written or oral statements or representations by any
official, employee, agent, attorney, consultant or independent contractor of the
City or the Company.

      13.4 Delays and Failures Beyond Control of Company

            Notwithstanding any other provision of this Agreement, the Company
shall not be liable for delay in the performance of, or failure to perform, in
whole or in part, its obligation pursuant to this Agreement due to strike, war
or act of war (whether an actual declaration of war is made or not),
insurrection, riot, act of public enemy, accident, fire, flood or other act of
God, technical failure where the Company has exercised all due care in the
prevention thereof, or other causes or events, to the extent that such any such
causes or events are beyond the control of the Company. In the event that any
such delay in performance or failure to perform affects only part of the
Company's capacity to perform, the Company shall perform to the maximum extent
it is able to do so and shall take all steps within its power to correct said
cause(s), it shall take all reasonable steps to do so in as expeditious a manner
as possible. The company shall notify DoITT in writing of the occurrence of any
event covered by this Section 13.4 within five (5) business days of the date
upon which the Company learns or should have learned of its occurrence.

                                      -40-
<PAGE>

      13.5 Notices

            Every notice, order, petition, document, or other direction or
communication to be served upon the City or the Company shall be in writing and
shall be sufficiently given if sent by registered or certified mail, return
receipt requested. Every such communication to the Company shall be sent to its
office located at c/o General Counsel, Metromedia Fiber Network, Inc. 1
Meadowlands Plaza, East Rutherford, New Jersey 07073 or to such other location
in New York City as the Company may designate, from time to time. Every
communication from the Company shall be sent to the individual, agency or
department designated in the applicable section of this Agreement, unless it is
to "the City," in which case such communication shall be sent to the
Commissioner of DoITT at 75 Park Place, 6th Floor, New York, New York 10007. A
required copy of each communication from the Company shall be sent to
Corporation Counsel New York City Law Department, 100 Church Street, New York,
New York 10007, Attention: Chief, Economic Development Division. Except as
otherwise provided herein, the mailing of such notice, direction, or order shall
be equivalent to direct personal notice and shall be deemed to have been given
when mailed. Any notice the Commissioner is required to give to the Company
pursuant to Section 11.2 hereof for which a cure period is ten (10) days or less
must be served by personal delivery, overnight mail service or facsimile
transmission.

      13.6 General Representations, Warranties and Covenants of the Company

            In addition to the representations, warranties, and covenants of the
Company to the City set forth elsewhere herein, the Company represents and
warrants to the City and covenants and agrees (which representations,
warranties, covenants and agreements shall not be affected or waived by any
inspection or examination made by or on behalf of the City), that, as of the
Effective Date:

            13.6.1 Organization, Standing, Power and Ownership

            The Company is a limited liability company duly organized, validly
existing and in good standing under the laws of the State of Delaware and is
duly authorized to do business in the State of New York, The Company has all
requisite power and authority to own or lease its properties and assets, to
conduct its business as currently conducted and to execute, delivery and perform
this Agreement and all other agreements entered into or delivered in connection
with or as contemplated hereby. Certified copies of the Company's organizational
and governing documents, as amended to date, have been delivered to the
Commissioner, and are completed and correct. The Company is qualified to do
business and is in good standing in the State of New York. The description of
the ownership of the Company n Appendix G attached hereto is accurate and
complete.

            13.6.2 Authorization; Non-Contravention

                  The execution, delivery and performance of this Agreement and
all other agreements, if any, entered into in connection with the transaction
contemplated hereby have been duly, legally and validly authorized by all
necessary action on the part of the Company and the Company has furnished the
City with a certified copy of authorizations for the execution and delivery of
this Agreement. This Agreement and all other agreements, if any, entered into in

                                      -41-
<PAGE>

connection with the transactions contemplated hereby have been duly executed and
delivered by the Company and constitute (or upon execution and delivery by the
Company and the City will constitute) the valid and binding obligations of the
Company, and are enforceable (or upon execution and delivery will be
enforceable) in accordance with their respective terms. The Company has
obtained, or is in the process of obtaining, the requisite authority to
authorize, execute and deliver this Agreement and to consummate the transactions
contemplated hereby and no other proceedings or other actions are necessary on
the part of the Company to authorize the execution and delivery of this
Agreement and the consummation of the transactions contemplated hereby. Neither
the execution and delivery of this Agreement by the Company nor the performance
of its obligations contemplated hereby will:

                  (a) conflict with, result in a materiel breach of or
      constitute a material default under (or with notice or lapse of time or
      both result in a material breach of or constitute a material default
      under) (i) any governing document of the Company or to the Company's
      knowledge, any agreement among the owners of the Company, or (ii) any
      statute, regulation, agreement, judgment, decree, court or administrative
      order or process or any commitment to which the Company is a party or by
      which it (or any of its properties or assets) is subject or bound;

                  (b) result in the creation of, or give any part the right to
      create, any material lien, charge, encumbrance or security interest upon
      the property and assets of the Company; or

                  (c) terminate, modify or accelerate, or give any third party
      the right to terminate, modify or accelerate, any provision or term of any
      contract, arrangement, agreement, license agreement or commitments, except
      for any event specified in (a) or (b) above which individually or in the
      aggregate would not have a material and adverse effect on the business,
      properties or financial condition of the Company or the System.

            1.1.3 Consent

                  No consent, approval or authorization of, or declaration or
filing with, any public, governmental or other authority is required for the
valid execution and delivery of this Agreement or any other agreement or
instrument, if any, executed or delivered in connection herewith.

            13.6.4 Compliance with Law

                  The Company certifies that, to the best of its knowledge after
diligent inquiry, it is in compliance with all laws, ordinances, decrees and
governmental rules and regulations applicable to the System and has filed, has
obtained or will file for all government licenses, permits, and authorizations
necessary for the operation, marketing and maintenance of the System.

            13.6.5 Litigation; Investigations

                  To the best of the Company's knowledge, after diligent
inquiry, except to the extent otherwise disclosed to the City: (a) there is no
civil, criminal, administrative,

                                      -42-
<PAGE>

arbitration or other proceeding, investigation or claim (including, without
limitation, proceedings with respect to unfair labor practice matters or labor
organization activity matters), pending or threatened against the Company or any
Affiliated Person, at law or in equity, or before any foreign, federal, state,
municipal or other governmental department, commission, board, bureau agency or
instrumentality (including without limitation any matter involving the granting
of a temporary or permanent injunction against the Company or any Affiliated
Person) that is reasonably likely to have a material adverse effect on the
business, operation, properties, assets or financial condition of the Company or
the System, or which questions the validity or prospective validity of this
Agreement, or of any essential element upon which this Agreement depends, or of
any action to be taken by the Company or any Affiliated Person; (b) no
investigation or review by any governmental entity with respect to the Company
or any Affiliated Person, relating to the System or any of the transactions
contemplated hereby is pending or is threatened against the Company or any
Affiliated Person, nor has any governmental entity indicated to the Company or
any Affiliated Person an intention to conduct the same; and (c) neither the
Company nor any Affiliated Person is subject to any outstanding order, writ,
injunction or decree which materially and adversely affects the business,
operations, properties, assets or financial condition of the System.

            13.6.6 Fees

                  The Company has paid all franchise, license or other fees and
charges which have become due pursuant to any franchise or permit to which it is
a party and has made adequate provisions for any such fees and charges which
have accrued, except where contested in good faith and by appropriate
proceedings.

            13.6.7 Criminal Acts

                  Neither the Company, or any Person holding a Controlling
Interest in the Company, nor any director or officer of the Company nor any
employee or agent of the Company nor any Controlling Person, acting pursuant to
the express direction, or with the actual consent of the foregoing, has been
convicted (where such conviction is a final, nonappealable judgment) or has
entered a guilty plea with respect to: (a) any criminal offense, excluding Class
B misdemeanors, violations, and traffic infractions as designated in the New
York State Penal Law or their equivalents in other jurisdictions; or (b) any
criminal offense, including, without limitation, bribery or fraud, arising out
of or in connection with (i) this Agreement, (ii) the award of the franchise
granted pursuant to this Agreement, or (iii) any act to be taken following the
Effective Date, pursuant to this Agreement the City, its officers, employees, or
agents.

            13.6.8 Misrepresentation

                  No material misrepresentation has been made, either oral or
written, intentionally or negligently, by or on behalf of the Company in this
Agreement, in connection with any submission to DoITT or the Commissioner,
including the Proposal, in connection with the negotiation of this Agreement.
For the purpose of this Section, Proposal means the response to the City's
Request for Proposals for Local High Capacity Telecommunications Services r
submitted to the City by the Company, and any amendments thereto.

                                      -43-
<PAGE>

      13.7 Additional Covenants

            Until the termination of this Agreement and the satisfaction in full
by the Company of its obligation under this Agreement, in consideration of the
franchise granted herein, the Company agrees that it will comply with the
following affirmative covenants, unless the City otherwise consents in writing:

            13.7.1 Compliance with Laws; Licenses and Permits

                  The Company shall comply with: (a) all applicable laws, rules,
regulations, orders, writs, decrees and judgments (including, but not limited to
those of the PSC and the FCC and any other federal or state agency or authority
of competent jurisdiction) affecting this Agreement, the franchise, and the
System; and (b) all local laws and all rules, regulations, orders, or other
directives of the City, DoITT, and the Commissioner issued pursuant to and in
accordance with this Agreement or otherwise.

                  The Company shall have the sole responsibility for obtaining
or causing to be obtained all permits, licenses and other forms of approval or
authorization necessary to construct, operate, maintain, upgrade, repair or
remove the System, or any part thereof. The Company will, prior to any
construction, operation, maintenance, upgrade, repair or removal of the System,
secure all necessary permits, license and authorizations in connection with the
construction, operation, maintenance, upgrade, repair or removal of the System,
or any part thereof, and will file all required registrations, applications,
reports and other documents with the FCC, the PSC and other entities exercising
jurisdiction over the provision of telecommunications services or the
construction of delivery systems therefor, except those which cannot be obtained
prior to the date hereof, which the Company will promptly seek to obtain. The
Company will promptly seek to obtain all leases, easements and equipment rental
or other agreements necessary for the maintenance and operation of the System.

                  The Company shall not permit to occur, or shall promptly take
corrective action if there shall occur, any event which (a) could result in the
revocation or termination of any such license or authorization, (b) could
materially and adversely affect any rights of the Company, or (c) permits or,
after notice or lapse of time or both, would permit, revocation or termination
of any such license or which materially and adversely affects or reasonably can
be expected to materially and adversely affect the System or any part thereof.

            137.2 Criminal Acts

                  The Company shall not permit any of the convictions or guilty
pleas of the types listed in Section 13.6.7 to occur during the term of this
Agreement, arising out of or in connection with (i) this Agreement, (ii) the
award of the franchise granted pursuant to this Agreement, or (iii) any act to
be taken following the Effective Date, pursuant to this Agreement by the City,
its officers, employees, or agents, and it shall be an Event of Default if any
such convictions or guilty pleas shall occur during the term of its Agreement,
provided that the City's right to take enforcement action under this Agreement
in the event of said conviction or guilty pleas shall arise only with respect to
any of the foregoing convictions or guilty pleas of the Company itself or, with
respect to any of the foregoing convictions or guilty pleas of any of the

                                      -44-
<PAGE>

other Persons specified in Section 13.6.7, if the Company shall have failed to
disassociate itself from, or terminate the employment of, said Person or Persons
within thirty (30) days after the Commissioner orders such disassociation.

            13.7.3 Maintain Existence

                  The Company will preserve and maintain its existence, its
business, and all of its rights and privileges necessary or desirable in the
normal conduct of said business in the Franchise Area, unless any such change
shall not have a material and adverse impact on the Company's ability to
construct, operate, maintain and upgrade the System as provided herein fulfill
the obligation of the Company hereunder. The Company shall maintain its good
standing in its state of organization and continue to qualify to do business and
remain in good standing in the State of New York. The Company shall conduct
business in accordance with its organizational and governing documents, and
shall comply with the material terms of all mortgages, indentures, leases,
contracts and other agreements and instruments binding upon it except where
contested in good faith and by appropriate proceedings.

            13.7.4 Condition of System

                  All of the properties, assets and equipment used as part of
the System will be maintained in good repair, working order and good condition.

      13.8 Binding Effect

            This Agreement shall be binding upon and inure to the benefit of the
parties hereto and their respective successors and permitted transferees and
assigns. All of the provisions of this Agreement shall apply to the Company, its
successors, and assigns.

      13.9 No Waiver; Cumulative Remedies

            No failure on the part of the City to exercise, and no delay in
exercising, any right hereunder shall operate as a waiver thereof, nor shall any
single or partial exercise of any such right preclude any other right, except as
provided herein, subject to the conditions and limitations established in this
Agreement. The rights and remedies provided herein are cumulative and not
exclusive of any remedies provided by law, and nothing contained in this
Agreement shall impair any of the rights of the City under applicable law,
subject in each case to the terms and conditions of this Agreement. A waiver of
any right or remedy by the City at any one time shall not affect the exercise of
such right or remedy or any other right or other remedy by the City at any other
time. In order for any waiver of the City to be effective, it must be in
writing. The failure of the City to take any action regarding a default or any
Event of Default by the Company shall not be deemed or construed to constitute a
waiver of or otherwise affect the right of the City to take any action permitted
by this Agreement at any other time regarding such default or Event of Default
which has not been cured, or with respect to any other default or Event of
Default by the Company.

                                      -45-
<PAGE>

      13.10 No Opposition

            The Company agrees that it shall not oppose the intervention by the
City in any suit, action, or proceeding involving the Company with respect to
the System or its construction, operation, maintenance, repair or removal, or to
any provision of this Agreement, Prior to the fifth anniversary of the Effective
Date, the Company agrees that it will not, at any time, set up against the City
any claim nor institute against the City any proceeding alleging that, pursuant
to any law, rule or regulation in effect on the Effective Date, a condition or
term of this Agreement is unreasonable, arbitrary, void, or otherwise
unenforceable, or that the City had no power or authority to make such term or
condition. By execution of this Agreement, the Company accepts the validity of
the terms and conditions of this Agreement in their entirety and hereby waives
and relinquishes, to the maximum extent permitted by applicable law, any and all
rights it has, in law or in equity, to assert in any manner at any time or in
any forum that this Agreement, the franchise granted pursuant to this Agreement,
the terms and conditions of this Agreement or the processes and procedures
pursuant to which this Agreement was entered into and the franchise was granted
are not consistent with applicable law in effect on the Effective Date.

13.11 Partial Invalidity

      If any section, subsection, sentence, clause, phrase or other portion of
this Agreement is, for any reason, declared invalid, in whole or in part, by any
court, agency, commission, legislative body, or other authority of competent
jurisdiction, such portion shall be deemed a separate, distinct, and independent
portion. Except as provided in Section 12 hereof such declaration shall not
affect the validity of the remaining portions hereof, which other portions hall
continue in full force and effect.

            13.12 Headings

      The headings contained in this Agreement are to facilitate reference only,
do not form a part of this Agreement, and shall not in any way affect the
construction or interpretation hereof. Terms such as "hereby," "herein,"
"hereof," "hereinafter," "hereunder," and "hereto" refer to this Agreement as a
whole and not to the particular sentence or paragraph where they appear, unless
the context otherwise requires. The term "may" is permissive; the terms "shall"
and "will" are mandatory, not merely directive. All references to any gender
shall be deemed to include both the male and female, and any reference by number
shall be deemed to include both the singular and plural, as the context may
require. Terms used in the plural include the singular, and vice versa, unless
the context otherwise requires.

            13.13 No Agency

      The Company shall conduct the work to be performed pursuant to this
Agreement as an independent contractor and not as an agent of the City.

                                      -46-
<PAGE>

      13.14 Governing Law

            This Agreement shall be deemed to be executed in the City of New
York, State of New York, and shall be governed in all respects, including
validity, interpretation and effect, and construed in accordance with the laws
of the State of New York, as applicable to contracts entered into and to be
performed entirely within that State.

      13.15 Survival of Representation and Warranties

            All representations and warranties contained in this Agreement shall
survive the Term.

      13.16 Delegation of City Rights

            The City reserves the right to delegate and redelegate, from time to
time and to the extent permitted by law, any of its rights or obligations under
this Agreement to any governmental body or organization, or official of any
other governmental body or organization and to revoke any such delegation or
redelegation. Any such delegation or redelegation by the City shall be effective
upon written notice by the City to the Company of such delegation or
redelegation. Upon receipt of such notice by the Company, the Company shall be
bound by all terms and conditions of the delegation or redelegation not in
conflict with this Agreement. Any such delegation, revocation or redelegation,
no matter how often made, shall not be deemed an amendment to this Agreement or
require the Company's consent.

      13.17 Claims Under Agreement

            The City and the Company agree that, except to the extent
inconsistent with applicable law, any and all claims asserted by or against the
City arising under this Agreement or related thereto shall be heard and
determined either in a court of the United States located in New York City
("Federal Court") or in a court of the State of New York located in the City and
County of New York ("New York State Court"). To effect this Agreement and
intent, the Company agrees that:

                  (a) If the City initiates any action against the Company in
      Federal Court or in New York State Court, service of process may be made
      on the Company as provided in Section 13.20 hereof;

                  (b) With respect to any action between the City and the
      Company in New York State Court, the Company hereby expressly waives and
      relinquishes any rights it might otherwise have (i) to move or dismiss on
      grounds of forum non conveniens: (ii) to remove to Federal Court outside
      of the City of New York; and (iii) to move for a change of venue to a
      court of the State of New York outside New York County;

                  (c) With respect to any action between the City and the
      Company in Federal Court, the Company expressly waives and relinquishes
      any right it might otherwise have to move to transfer the action to a
      United States Court outside the City of New York; and

                                      -47-
<PAGE>

                  (d) If the Company commences any action against the City in a
      court located other than in the City and State of New York, then, upon
      request of the City, the Company shall either consent to a transfer of the
      action to a court of competent jurisdiction located in the City and State
      of New York or, if the court where the action is initially brought will
      not or cannot transfer the action, the Company shall consent to dismiss
      such action without prejudice and may thereafter reinstitute the action in
      a court of competent jurisdiction in the City of New York. When the
      Company either gives such consent or dismisses such action, to allow for
      such reinstitution, the City agrees, where it is able, to waive any statue
      of limitation, provided the Company has brought such action at least three
      (3) months prior to the expiration of the statute of limitation and has
      provided the City with notice pursuant to the Agreement.

      13.18 Modification

            Except as otherwise provided in this Agreement, any Appendix to this
Agreement or applicable law, no provision of this Agreement nor any Appendix to
this Agreement shall be amended or otherwise modified, in whole or in part,
except by a written instrument, duly executed by the City and the Company, and
approved as required by applicable law.

      13.19 Maintain Office

            The Company agrees to maintain an office in the City of New York
throughout the Term of this Agreement. Such office is currently located at: 810
7th Avenue, 29th Floor, New York, New York 10019.

      13.20 Service of Process

            Process may be served either in person, wherever the Company may be
found, by registered mail addressed to the Company at its office in the City, or
as set forth in Section 13.5 of this Agreement, to such other location as the
Company may provide to the City in writing, or to the Secretary of State of the
State of New York.

      13.21 Compliance With Certain City Requirements

            The Company agrees to comply in all respects with the City's
"MacBride Principles', a copy of which is attached at Appendix H hereto. The
Company agrees to comply in all respects with the Local Law 33 of 1997, a copy
of which is attached at Appendix I hereto. The Company agrees to comply in all
respects with the City's Vendor Information Exchange System, as the same may be
amended from time to time.

      13.22 Matching Provision

                  (a) In the event that the City grants, renews or renegotiates
      one or more franchise(s), agreement(s) or similar authorization(s), for
      the provision of local, high-capacity telecommunications services or
      similar services in the Franchise Area, and such franchise(s),
      agreement(s) or authorization(s) contain provisions imposing lesser
      obligations on the grantee(s) thereof than are imposed by the provisions
      of this

                                      -48-
<PAGE>

      Agreement, the Company may at any time petition the City for a
      modification of this Agreement.

                  (b) The City shall consider any petition for modification
      pursuant to Section 13.22(a) hereof, and shall grant such prospective
      modification(s) to the extent that the City reasonably determines that
      such modification(s) must be granted in order to ensure fair and equal
      treatment among the Company and other franchises, provided that the
      Company establishes by a preponderance of the evidence each of the
      following:

                        (i) that the Company is in compliance with this
            Agreement and the other franchise(s), agreement(s) or
            authorization(s) were not granted as a result of the Company's
            failure to comply, on a timely basis, with the provision of this
            Agreement;

                        (ii) that the other franchise(s), agreement(s) or
            authorization(s) allow substantially similar services to those
            offered by the Company under this Agreement;

                        (iii) that the obligations imposed on the Company under
            this Agreement, taken as a whole, place the Company at a substantial
            competitive disadvantage in relation to the obligations imposed on
            the grantee(s) holders of the other franchise(s), agreement(s) or
            authorization(s), taken as a whole; and

                        (iv) that the reason for the City's imposition of or
            failure to act with respect to a lesser obligation under the other
            franchise(s), agreement(s) or authorization(s) is not due to the
            differing nature of the City's regulatory authority with respect to
            the other communications systems or justified by the relative
            benefits, in whatever form, received by the City due to the
            operation of other communications systems.

                  (c) For the purposes of this Section 13.22, in order to
      promote fair comparison, to the extent possible all benefits and burdens
      shall be quantified monetarily.

      13.23 Joint Services

            Notwithstanding any other provision of this Agreement, in the event
the Company provides any Telecommunications Services in conjunction with, in a
joint venture with or in any other arrangement with (the "Joint Services") any
one or more entities that the City has also authorized to provide local
high-capacity telecommunications services (the "Other Franchisees"):

                  (a) no revenues with respect to Telecommunications Services
      being provided by such Other Franchisees, other than Joint Services, shall
      be included in the Company's Gross Revenue, so long as the revenues
      distributed to or otherwise retained by the Other Franchisees with respect
      to Joint Services are subject to the terms of such other Franchisees' own
      agreements with the City; and

                                      -49-
<PAGE>

                  (b) only those revenues received by the Company with respect
      to Joint Services and not distributed to or otherwise retained by the
      Other Franchisees shall be included in the Company's Gross Revenue, so
      long as the revenues distributed to or otherwise retained by the Other
      Franchisees with respect to Joint Services are subject to the terms of
      such other Franchisees' own agreements with the City.

                                -- end of page --

                        [signatures appear on next page]

                                      -50-
<PAGE>

      IN WITNESS WHEREOF, the party of the first part, by its Deputy Mayor, duly
authorized by the Charter of the City of New York, has caused the corporate name
of said City to be hereunto signed and the corporate seal of said City to be
hereunto affixed and the party of the second part, by its officers thereunto
duly authorized, has caused its name to be hereunto signed and its seal to be
hereunto affixed as of the date and year first above written.

                                   THE CITY OF NEW YORK

                                   By:       /s/ Joseph Lhota
                                       -----------------------------
                                                Deputy Mayor

                                                   2-29-00
                                   ---------------------------------
                                                    Date

Approved as to form:

Corporation Counsel

/s/ [illegible]
------------------------------------
Acting Corporation Counsel

                                   METROMEDIA FIBER NETWORK NYC, INC.

                                   By: /s/ Nick Tanzi
                                       -----------------------------
                                   Name: Nick Tanzi
                                   Title: President

(Seal)
                                                       --------------
Attest: /s/ [illegible]                                APPROVED AS TO
        --------------------------------               /s/ [ILLEGIBLE]
           City Clerk                                       FORM
                                                       --------------

                                      -51-
<PAGE>

CITY OF NEW YORK        )
                        )  ss:
STATE OF NEW YORK       )

      I , Debra Samuelson a Notary Public in and for the State of New York,
residing therein, duly commissioned and sworn, do hereby certify that Joseph
Lhota, Deputy Mayor of the City of New York, party to the above instrument,
personally appeared before me in said State on the 29 day of February , 2000,
the said Joseph Lhota being personally well known to me and who executed the
foregoing instrument and acknowledged to me that he executed the same as his
free act and deed in his capacity as Deputy Mayor of the City of New York.

      Given under my hand and seal, this 29 day of February , 2000.

                                          /s/ Debra Samuelson
                                              Notary Public

My Commission Expires: 2-10-07

CITY OF NEW YORK        )
                        )  ss:
STATE OF NEW YORK       )

      I, Yvette Kitrosser a Notary Public in and for the State of New York,
residing therein, duly commissioned and sworn, do hereby certify that Nick
Tanzi, party to the above instrument, personally appeared before me in said
State on the 16 day of February, 2000, the said President being personally well
known to me and who executed the foregoing instrument and acknowledged to me
that he executed the same as his free act and deed.

      Given under my hand and seal, this 16 day of February, 2000.

                                        /s/ Yvette Kitrosser
                                        Notary Public

                                  YVETTE KITROSSER
                         Notary Public State of New York
My Commission Expires:             No. 31-5008842
                           Qualified in New York County
                          Commission Expires Mar. 1, 2001

                                      -52-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00003-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00003-of-00352.parquet"}]]